v3.19.3.a.u2
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2019
Feb. 18, 2020
Jun. 30, 2019
Document and Entity Information      
Entity Registrant Name Ares Commercial Real Estate Corp    
Entity Central Index Key 0001529377    
Document Type 10-K    
Document Period End Date Dec. 31, 2019    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Entity Current Reporting Status Yes    
Entity Filer Category Accelerated Filer    
Entity Common Stock, Shares Outstanding   33,389,008  
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Public Float     $ 379,337,480
v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
ASSETS    
Cash and cash equivalents $ 5,256 $ 11,089
Restricted cash 379 379
Loans held for investment ($515,896 and $289,576 related to consolidated VIEs, respectively) 1,682,498 1,524,873
Real estate owned, net 37,901 0
Other assets ($1,309 and $843 of interest receivable related to consolidated VIEs, respectively; $41,104 and $51,582 of other receivables related to consolidated VIEs, respectively) 58,100 66,983
Total assets 1,784,134 1,603,324
LIABILITIES    
Secured funding agreements 728,589 777,974
Notes payable 54,708 0
Secured term loan 109,149 108,345
Collateralized loan obligation securitization debt (consolidated VIE) 443,177 270,737
Due to affiliate 2,761 3,163
Dividends payable 9,546 8,914
Other liabilities ($718 and $541 of interest payable related to consolidated VIEs, respectively) 9,865 8,604
Total liabilities 1,357,795 1,177,737
Commitments and contingencies (Note 6)
STOCKHOLDERS' EQUITY    
Common stock, par value $0.01 per share, 450,000,000 shares authorized at December 31, 2019 and 2018 and 28,865,610 and 28,755,665 shares issued and outstanding at December 31, 2019 and 2018, respectively 283 283
Additional paid-in capital 423,619 421,739
Accumulated earnings 2,437 3,565
Total stockholders’ equity 426,339 425,587
Total liabilities and stockholders’ equity $ 1,784,134 $ 1,603,324
v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Loans held for investment related to consolidated VIE $ 515,896 $ 289,576
Other assets, interest receivable related to consolidated VIE 1,309 843
Other assets, certificates receivable related to consolidated VIE 41,104 51,582
Other liabilities, interest payable related to consolidated VIE $ 718 $ 541
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 450,000,000 450,000,000
Common stock, shares issued 28,865,610 28,755,665
Common stock, shares outstanding 28,865,610 28,755,665
v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue:      
Interest income from loans held for investment $ 114,784 $ 118,284 $ 97,541
Interest expense (62,583) (63,002) (51,193)
Net interest margin 52,201 55,282 46,348
Revenue from real estate owned 25,058 0 0
Total revenue 77,259 55,282 46,348
Expenses:      
Management and incentive fees to affiliate 7,363 7,418 6,569
Professional fees 2,194 1,945 1,674
General and administrative expenses 4,188 3,307 2,828
General and administrative expenses reimbursed to affiliate 3,026 3,570 3,899
Expenses from real estate owned 22,982 0 0
Total expenses 39,753 16,240 14,970
Early extinguishment of debt costs 0 0 (768)
Income before income taxes 37,506 39,042 30,610
Income tax expense, including excise tax 515 446 178
Net income attributable to ACRE 36,991 38,596 30,432
Less: Net income attributable to non-controlling interests 0 0 (25)
Net income attributable to common stockholders $ 36,991 $ 38,596 $ 30,407
Earnings per common share:      
Basic earnings per common share (in dollars per share) $ 1.29 $ 1.35 $ 1.07
Diluted earnings per common share (in dollars per share) $ 1.28 $ 1.35 $ 1.07
Weighted average number of common shares outstanding:      
Basic weighted average shares of common stock outstanding (in shares) 28,609,282 28,529,439 28,478,237
Diluted weighted average shares of common stock outstanding (in shares) 28,846,641 28,656,660 28,550,945
v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Earnings (Deficit)
Total Stockholders’ Equity
Non-Controlling Interests
Balance (in shares) at Dec. 31, 2016   28,482,756        
Balance at Dec. 31, 2016 $ 429,673 $ 283 $ 420,056 $ (1,310) $ 419,029 $ 10,644
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation (in shares)   116,160        
Stock‑based compensation 581   581   581  
Net income 30,432     30,407 30,407 25
Dividends declared (30,847)     (30,847) (30,847)  
Contributions from non-controlling interests 12         12
Distributions to non-controlling interests (10,681)         (10,681)
Balance (in shares) at Dec. 31, 2017   28,598,916        
Balance at Dec. 31, 2017 419,170 $ 283 420,637 (1,750) 419,170 0
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation (in shares)   156,749        
Stock‑based compensation 1,102   1,102   1,102  
Net income 38,596     38,596 38,596 0
Dividends declared $ (33,281)     (33,281) (33,281)  
Balance (in shares) at Dec. 31, 2018 28,755,665 28,755,665        
Balance at Dec. 31, 2018 $ 425,587 $ 283 421,739 3,565 425,587 0
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation (in shares)   109,945        
Stock‑based compensation 1,880   1,880   1,880  
Net income 36,991     36,991 36,991 0
Dividends declared $ (38,119)     (38,119) (38,119)  
Balance (in shares) at Dec. 31, 2019 28,865,610 28,865,610        
Balance at Dec. 31, 2019 $ 426,339 $ 283 $ 423,619 $ 2,437 $ 426,339 $ 0
v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating activities:      
Net income $ 36,991 $ 38,596 $ 30,432
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Amortization of deferred financing costs 6,569 5,720 7,608
Accretion of deferred loan origination fees and costs (7,013) (6,949) (6,578)
Stock-based compensation 1,880 1,102 581
Depreciation of real estate owned 667 0 0
Early extinguishment of debt costs 0 0 768
Changes in operating assets and liabilities:      
Other assets (6,435) 198 (2,530)
Due to affiliate (402) 535 (71)
Other liabilities 195 16 1,066
Net cash provided by (used in) operating activities 32,452 39,218 31,276
Investing activities:      
Issuance of and fundings on loans held for investment (673,160) (543,077) (900,289)
Principal repayment of loans held for investment 492,884 695,183 411,298
Proceeds from sale of mortgage loans held for sale 0 0 73,900
Receipt of origination fees 7,536 5,818 9,323
Purchases of capitalized additions to real estate owned (1,686) 0 0
Net cash provided by (used in) investing activities (174,426) 157,924 (405,768)
Financing activities:      
Proceeds from secured funding agreements 793,801 642,241 923,882
Repayments of secured funding agreements (843,186) (822,227) (746,635)
Proceeds from notes payable 56,155 0 0
Payment of secured funding costs (5,731) (2,322) (8,405)
Proceeds from issuance of debt of consolidated VIEs 172,673 0 272,927
Repayments of secured term loan 0 0 (45,000)
Dividends paid (37,487) (32,088) (30,531)
Payment of offering costs (84) 0 0
Contributions from non-controlling interests 0 0 12
Distributions to non-controlling interests 0 0 (10,681)
Net cash provided by (used in) financing activities 136,141 (214,396) 355,569
Change in cash, cash equivalents and restricted cash (5,833) (17,254) (18,923)
Cash, cash equivalents and restricted cash, beginning of period 11,468 28,722 47,645
Cash, cash equivalents and restricted cash, end of period 5,635 11,468 28,722
Supplemental Information:      
Interest paid during the period 54,595 56,719 41,891
Income taxes paid during the period 668 360 240
Supplemental disclosure of noncash investing and financing activities:      
Dividends declared, but not yet paid 9,546 8,914 7,722
Other receivables related to consolidated VIEs $ 41,104 $ 51,582 $ 0
v3.19.3.a.u2
ORGANIZATION
12 Months Ended
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION
 ORGANIZATION

Ares Commercial Real Estate Corporation (together with its consolidated subsidiaries, the “Company” or “ACRE”) is a specialty finance company primarily engaged in originating and investing in commercial real estate loans and related investments. Through Ares Commercial Real Estate Management LLC (“ACREM” or the Company’s “Manager”), a Securities and Exchange Commission (“SEC”) registered investment adviser and a subsidiary of Ares Management Corporation (NYSE: ARES) (“Ares Management” or “Ares”), a publicly traded, leading global alternative asset manager, it has investment professionals strategically located across the United States and Europe who directly source new loan opportunities for the Company with owners, operators and sponsors of commercial real estate (“CRE”) properties. The Company was formed and commenced operations in late 2011. The Company is a Maryland corporation and completed its initial public offering (the “IPO”) in May 2012. The Company is externally managed by its Manager, pursuant to the terms of a management agreement (the “Management Agreement”).
 
The Company operates as one operating segment and is primarily focused on directly originating and managing a diversified portfolio of CRE debt-related investments for the Company’s own account. The Company’s target investments include senior mortgage loans, subordinated debt, preferred equity, mezzanine loans and other CRE investments, including commercial mortgage backed securities. These investments are generally held for investment and are secured, directly or indirectly, by office, multifamily, retail, industrial, lodging, senior-living, self storage, student housing, residential and other commercial real estate properties, or by ownership interests therein.

The Company has elected and qualified to be taxed as a real estate investment trust (“REIT”) for United States federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2012. The Company generally will not be subject to United States federal income taxes on its REIT taxable income as long as it annually distributes all of its REIT taxable income prior to the deduction for dividends paid
to stockholders and complies with various other requirements as a REIT.
v3.19.3.a.u2
SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated.

Variable Interest Entities

The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE.
 
To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE.

To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company.
 
For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements.
 
The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change. See Note 13 included in these consolidated financial statements for further discussion of the Company’s VIEs.
 
Cash, Cash Equivalents and Restricted Cash

Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short‑term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and statements of cash flows.

Restricted cash includes deposits required under certain Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements).

The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows ($ in thousands):
 
For the years ended December 31,
 
2019
 
2018
 
2017
Cash and cash equivalents
$
5,256

 
$
11,089

 
$
28,343

Restricted cash
379

 
379

 
379

Total cash, cash equivalents and restricted cash shown in the Company's consolidated statements of cash flows
$
5,635

 
$
11,468

 
$
28,722



Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and restricted cash, loans held for investment and interest receivable. The Company places its cash and cash equivalents with financial institutions and, at times, cash held may exceed the Federal Deposit Insurance Corporation insured limit. The Company has exposure to credit risk on its loans held for investment. The Company and the Company’s Manager seek to manage credit risk by performing due diligence prior to origination or acquisition and through the use of non‑recourse financing, when and where available and appropriate.

Loans Held for Investment

The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired. Impairment occurs when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan. If a loan is considered to be impaired, the Company will record an allowance to reduce the carrying value of the loan to the present value of expected future cash flows discounted at the loan’s contractual effective rate.

Each loan classified as held for investment is evaluated for impairment on a quarterly basis. Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such impairment analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors.

In addition, the Company evaluates the entire portfolio to determine whether the portfolio has any impairment that requires a valuation allowance on the remainder of the loan portfolio. For the years ended December 31, 2019, 2018 and 2017, the Company did not recognize any impairment charges with respect to its loans held for investment.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.
 
Preferred equity investments, which are subordinate to any loans but senior to common equity, are accounted for as loans held for investment and are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired, and are included within loans held for investment in the Company’s consolidated balance sheets. The Company accretes or amortizes any discounts or premiums over the life of the related loan held for investment utilizing the effective interest method.
 
Real Estate Owned

Real estate assets are carried at their estimated fair value at acquisition and are presented net of accumulated depreciation and impairment charges. The Company allocates the purchase price of acquired real estate assets based on the fair value of the acquired land, building, furniture, fixtures and equipment.

Real estate assets are depreciated using the straight-line method over estimated useful lives of up to 40 years for buildings and improvements and up to 15 years for furniture, fixtures and equipment. Renovations and/or replacements that improve or extend the life of the real estate asset are capitalized and depreciated over their estimated useful lives. The cost of ordinary repairs and maintenance are expensed as incurred.

Real estate assets are evaluated for indicators of impairment on a quarterly basis. Factors that the Company may consider in its impairment analysis include, among others: (1) significant underperformance relative to historical or anticipated operating results; (2) significant negative industry or economic trends; (3) costs necessary to extend the life or improve the real estate asset; (4) significant increase in competition; and (5) ability to hold and dispose of the real estate asset in the ordinary course of business. A real estate asset is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate asset over the estimated remaining holding period is less than the carrying amount of such real estate asset. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate asset. An impairment charge is recorded equal to the excess of the carrying value of the real estate asset over the fair value. When determining the fair value of a real estate asset, the Company makes certain assumptions including, but not limited to, consideration of projected operating cash flows, comparable selling prices and projected cash flows from the eventual disposition of the real estate asset based upon the Company’s estimate of a capitalization rate and discount rate.

The Company reviews its real estate assets, from time to time, in order to determine whether to sell such assets. Real estate assets are classified as held for sale when the Company commits to a plan to sell the asset, when the asset is being marketed for sale at a reasonable price and the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year. Real estate assets that are held for sale are carried at the lower of the asset’s carrying amount or its fair value less costs to sell.

Debt Issuance Costs

Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on (i) Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable and the Secured Term Loan (both defined in Note 5 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability, in the Company’s consolidated balance sheets. Amortization of debt issuance costs for the note payable on the hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable) is included within expenses from real estate owned in the Company’s consolidated statements of operations.

The original issue discount (“OID”) on amounts drawn under the Company’s Secured Term Loan represents a discount to the face amount of the drawn debt obligations. The OID is amortized over the term of the Secured Term Loan using the effective interest method and is included within interest expense in the Company’s consolidated statements of operations while the unamortized balance is included as a reduction to the carrying amount of the Secured Term Loan in the Company’s consolidated balance sheets.

Revenue Recognition

Interest income from loans held for investment is accrued based on the outstanding principal amount and the contractual terms of each loan. For loans held for investment, origination fees, contractual exit fees and direct loan origination costs are also recognized in interest income from loans held for investment over the initial loan term as a yield adjustment using the effective interest method.

Revenue from real estate owned represents revenue associated with the operations of a hotel property classified as real estate owned. Revenue from the operation of the hotel property is recognized when guestrooms are occupied, services have been rendered or fees have been earned. Revenues are recorded net of any discounts and sales and other taxes collected from customers. Revenues consist of room sales, food and beverage sales and other hotel revenues.
Net Interest Margin and Interest Expense

Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans held for investment as compared to its use of debt leverage. The Company includes interest income from its loans held for investment and interest expense related to its Secured Funding Agreements, Notes Payable, securitizations debt and the Secured Term Loan (individually defined in Note 5 included in these consolidated financial statements) in net interest margin. For the years ended December 31, 2019, 2018 and 2017, interest expense is comprised of the following ($ in thousands):
 
For the years ended December 31,
 
2019
 
2018
 
2017
Secured funding agreements
$
32,859

 
$
43,039

 
$
29,272

Notes payable (1)
867

 

 

Securitizations debt
19,950

 
11,434

 
8,330

Secured term loan
8,907

 
8,529

 
13,591

Interest expense
$
62,583

 
$
63,002

 
$
51,193

___________________________________________________________________________

(1)
Excludes interest expense on the $28.3 million note payable, which is secured by a hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable). Interest expense on the $28.3 million note payable is included within expenses from real estate owned in the Company’s consolidated statements of operations.
Income Taxes

The Company has elected and qualified for taxation as a REIT commencing with its taxable year ended December 31, 2012. As a result of the Company’s REIT qualification and its distribution policy, the Company does not generally pay United States federal corporate level income taxes. Many of the REIT requirements, however, are highly technical and complex. To continue to qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement that the Company distributes annually to its stockholders at least 90% of the Company’s REIT taxable income prior to the deduction for dividends paid. To the extent that the Company distributes less than 100% of its REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), the Company will pay tax at regular corporate rates on that undistributed portion. Furthermore, if the Company distributes less than the sum of 1) 85% of its ordinary income for the calendar year, 2) 95% of its capital gain net income for the calendar year, and 3) any undistributed shortfall from its prior calendar year (the “Required Distribution”) to its stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then it is required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if the Company elects to retain any of its net capital gain for any tax year, it must notify its stockholders and pay tax at regular corporate rates on the retained net capital gain. The stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If it is determined that the Company’s estimated current year taxable income will be in excess of estimated dividend distributions (including capital gain dividend) for the current year from such income, the Company accrues excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations. Excise tax expense is included in the line item income tax expense, including excise tax in the consolidated statements of operations included in this annual report on Form 10-K.

The Company formed a wholly-owned subsidiary, ACRC Lender W TRS LLC (“ACRC W TRS”), in December 2013 in order to issue and hold certain loans intended for sale. The Company also formed a wholly-owned subsidiary, ACRC 2017-FL3 TRS LLC (“FL3 TRS”), in March 2017 in order to hold a portion of the CLO Securitization (as defined below), including the portion that generates excess inclusion income. Additionally, the Company also formed a wholly-owned subsidiary, ACRC WM Tenant LLC (“ACRC WM”), in March 2019 in order to lease the hotel property classified as real estate owned, which was acquired on March 8, 2019. Entity classification elections to be taxed as a corporation and taxable REIT subsidiary (“TRS”) elections were made with respect to ACRC W TRS, FL3 TRS and ACRC WM. A TRS is an entity taxed as a corporation that has not elected to be taxed as a REIT, in which a REIT directly or indirectly holds equity, and that has made a joint election with such REIT to be treated as a TRS. A TRS generally may engage in any business, including investing in assets and engaging in activities that could not be held or conducted directly by the Company without jeopardizing its qualification as a REIT. A TRS is subject to applicable United States federal, state and local income tax on its taxable income. In addition, as a REIT, the Company also may be subject to a 100% excise tax on certain transactions between it and its TRS that are not conducted on an arm’s-length basis. For financial reporting purposes, a provision for current and deferred taxes has been established for the portion of the Company’s GAAP consolidated earnings recognized by ACRC W TRS, FL3 TRS and ACRC WM. The income tax provision is included in the line item income tax expense, including excise tax in the consolidated statements of operations included in this annual report on Form 10-K.

FASB ASC Topic 740, Income Taxes (“ASC 740”), prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has analyzed its various federal and state filing positions and believes that its income tax filing positions and deductions are well documented and supported. As of December 31, 2019 and 2018, based on the Company’s evaluation, there is no reserve for any uncertain income tax positions. ACRC W TRS, FL3 TRS and ACRC WM recognize interest and penalties, if any, related to unrecognized tax benefits within income tax expense in the consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the consolidated balance sheets.

Comprehensive Income

For the years ended December 31, 2019, 2018 and 2017, comprehensive income equaled net income; therefore, a separate consolidated statement of comprehensive income is not included in the accompanying consolidated financial statements.

Stock‑Based Compensation

The Company recognizes the cost of stock‑based compensation, which is included within general and administrative expenses in the Company’s consolidated statements of operations. The fair value of the time vested restricted stock or restricted stock units (“RSUs”) granted is recorded to expense on a straight‑line basis over the vesting period for the award, with an offsetting increase in stockholders’ equity. For grants to directors and officers and employees of the Manager, the fair value is determined based upon the market price of the stock on the grant date.

Earnings per Share

The Company calculates basic earnings (loss) per share by dividing net income (loss) allocable to common stockholders for the period by the weighted average shares of common stock outstanding for that period after consideration of the earnings (loss) allocated to the Company’s restricted stock, which are participating securities as defined in GAAP. Diluted earnings (loss) per share takes into effect any dilutive instruments, such as restricted stock, RSUs and convertible debt, except when doing so would be anti‑dilutive. See Note 8 included in these consolidated financial statements for the earnings per share calculations.

Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates.

Recent Accounting Pronouncements
    
In June 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard replaced the incurred loss impairment methodology pursuant to GAAP with a methodology that reflects current expected credit losses (“CECL”) on full commitment balances and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU No. 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. ASU No. 2016-13 is to be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Subsequent increases and decreases to estimated expected credit losses will flow through the Company’s consolidated statements of operations. The CECL reserve required under ASU No. 2016-13 is a valuation account that is deducted from the carrying value of loans held for investment on the Company's consolidated balance sheets. Future funding commitments on the Company's loans are also subject to a CECL reserve. The CECL reserve related to future loan fundings is recorded as a component of other liabilities in the Company's consolidated balance sheets and changes in this component of the CECL reserve will flow through the Company’s consolidated statements of operations, similar to the accounting for the CECL reserve on funded amounts.
 
The Company plans to estimate its CECL reserve primarily using a probability-weighted model that considers the likelihood of default and expected loss given default for each such individual loan. Estimating a CECL reserve requires significant judgment, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) capital senior to us when we are the subordinate lender, and (iv) our current and future view of the macroeconomic environment. Upon adoption of ASU No. 2016-13 on January 1, 2020, the Company expects that, based on current expectations of future economic conditions, its allowance for credit losses on loans held for investment, including future loan funding commitments, will be between $4.8 million and $6.7 million or 0.25% and 0.35% of the Company's total loan commitment balance of $1.9 billion as of December 31, 2019. The Company currently does not have any provision for loan losses recorded in its consolidated financial statements.
v3.19.3.a.u2
LOANS HELD FOR INVESTMENT
12 Months Ended
Dec. 31, 2019
Receivables [Abstract]  
LOANS HELD FOR INVESTMENT
LOANS HELD FOR INVESTMENT

As of December 31, 2019, the Company’s portfolio included 50 loans held for investment, excluding 88 loans that were repaid, sold or converted to real estate owned since inception. The aggregate originated commitment under these loans at closing was approximately $1.9 billion and outstanding principal was $1.7 billion as of December 31, 2019. During the year ended December 31, 2019, the Company funded approximately $679.2 million of outstanding principal, received repayments of $482.4 million of outstanding principal and converted one loan with outstanding principal of $38.6 million to real estate owned as described in more detail in the tables below. As of December 31, 2019, 93.0% of the Company’s loans have London Interbank Offered Rate (“LIBOR”) floors, with a weighted average floor of 1.76%, calculated based on loans with LIBOR floors. References to LIBOR or “L” are to 30-day LIBOR (unless otherwise specifically stated).
 
The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of December 31, 2019 and 2018 ($ in thousands):

 
As of December 31, 2019
 
Carrying Amount (1)
 
Outstanding Principal (1)
 
Weighted Average Unleveraged Effective Yield (2)
 
Weighted Average Remaining Life (Years)
Senior mortgage loans
$
1,622,666

 
$
1,632,164

 
6.5
%
 
1.5
Subordinated debt and preferred equity investments
59,832

 
60,730

 
15.1
%
 
2.6
Total loans held for investment portfolio
$
1,682,498

 
$
1,692,894

 
6.8
%
 
1.6

 
As of December 31, 2018
 
Carrying Amount (1)
 
Outstanding Principal (1)
 
Weighted Average Unleveraged Effective Yield (2)
 
Weighted Average Remaining Life (Years)
Senior mortgage loans
$
1,489,708

 
$
1,498,530

 
7.0
%
 
1.7
Subordinated debt and preferred equity investments
35,165

 
36,213

 
14.9
%
 
4.3
Total loans held for investment portfolio
$
1,524,873

 
$
1,534,743

 
7.1
%
 
1.8
_______________________________________________________________________________

(1)
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
(2)
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of December 31, 2019 and 2018 as weighted by the outstanding principal balance of each loan.

A more detailed listing of the Company’s loans held for investment portfolio based on information available as of December 31, 2019 is as follows ($ in millions, except percentages):

Loan Type
 
Location
 
Outstanding Principal (1)
 
Carrying Amount (1)
 
Interest Rate
 
Unleveraged Effective Yield (2)
 
Maturity Date (3)
 
Payment Terms (4)
 
Senior Mortgage Loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mixed-use

FL

$100.6

$99.9

L+4.25%

7.8%

Feb 2021

I/O

Multifamily

FL

89.7

89.6

L+4.75%

6.8%

Feb 2020
(5)
I/O

Multifamily

TX

75.0

74.7

L+2.85%

5.0%

Oct 2022

I/O

Office

IL

69.2

69.0

L+3.75%

6.1%

Dec 2020

I/O

Hotel

OR/WA

68.1

67.7

L+3.45%

5.9%

May 2021

I/O

Hotel

Diversified

58.9

58.6

L+3.60%

6.2%

Sep 2021

I/O

Office

IL

57.0

56.8

L+3.95%

6.3%

Jun 2021

I/O

Industrial

FL

52.5

52.0

L+6.10%

8.8%

Oct 2022

I/O

Office

NC

49.6

49.0

L+4.25%

8.6%

Mar 2021

I/O

Mixed-use

CA

49.0

48.8

L+4.00%

6.3%

Apr 2021

I/O

Multifamily

FL

45.4

45.3

L+4.75%

6.8%

Feb 2020
(5)
I/O

Multifamily

TX

42.7

42.6

L+3.30%

5.4%

Dec 2020

I/O

Multifamily

FL

42.4

42.1

L+2.60%

5.5%

Jan 2022

I/O

Student Housing

CA

41.7

41.7

L+3.95%

6.3%

Jul 2020

I/O

Student Housing

TX

41.0

40.8

L+4.75%

7.1%

Jan 2021

I/O

Hotel

CA

40.0

39.9

L+4.12%

6.2%

Jan 2021

I/O

Multifamily

IL

39.2

39.0

L+3.50%

6.5%

Nov 2020

I/O

Office

GA

36.9

36.3

L+3.05%

5.8%

Dec 2022

I/O

Multifamily

KS

35.8

35.5

L+3.25%

5.5%

Nov 2022

I/O

Hotel

MI

35.2

35.2

L+4.40%

6.2%

Jul 2020
(6)
I/O

Industrial

NC

34.8

34.6

L+4.05%

6.1%

Mar 2024

I/O

Mixed-use

TX

33.8

33.4

L+3.75%

6.7%

Sep 2022

I/O

Hotel

IL

32.9

32.7

L+4.40%

6.8%

May 2021

I/O

Hotel

MN

31.5

31.3

L+3.55%

6.0%

Aug 2021

I/O

Office

CA

30.9

30.6

L+3.35%

6.0%

Nov 2022

I/O

Multifamily

NY

30.2

30.1

L+3.20%

5.3%

Dec 2020

I/O

Student Housing

NC

30.0

29.8

L+3.15%

5.9%

Feb 2022

I/O

Multifamily

PA

29.3

29.2

L+3.00%

5.9%

Dec 2021

I/O

Multifamily

TX

27.5

27.4

L+3.20%

5.5%

Oct 2020

I/O

Office

IL

27.5

27.2

L+3.80%

6.2%

Jan 2023

I/O

Multifamily

CA

26.8

26.7

L+3.85%

6.1%

Jul 2020

I/O

Student Housing

AL

24.1

24.1

L+4.45%

6.8%

Feb 2020

I/O

Student Housing

TX

24.0

23.9

L+4.10%

6.4%

Jan 2021

I/O

Student Housing

FL

22.0

21.8

L+3.25%

5.9%

Aug 2022

I/O

Industrial

CA

21.0

20.8

L+4.50%

7.4%

Dec 2021

I/O

Self Storage

FL

19.5

19.4

L+3.50%

6.0%

Mar 2022

I/O

Multifamily

FL

19.2

19.1

L+4.00%

6.1%

Nov 2020

I/O

Office

FL

18.4

18.4

L+4.30%

6.6%

Apr 2020

I/O

Office

CA

17.7

17.6

L+3.40%

6.3%

Nov 2021

I/O

Office

NC

13.2

13.0

L+3.51%

6.7%

May 2023

I/O

Office

TX

13.1

12.8

L+4.05%

7.5%

Nov 2021

I/O

Industrial

CA

12.7

12.6

L+3.75%

6.3%

Mar 2023

I/O

Residential

CA

11.6

11.5

13.00%
(7)
22.5%

Feb 2020

I/O

Office

NC

8.6

8.5

L+4.00%

6.7%

Nov 2022

I/O

Multifamily

SC

2.0

1.7

L+6.50%

10.1%

Sep 2022

I/O

Subordinated Debt and Preferred Equity Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Office

NJ

17.0

16.4

12.00%

12.8%

Jan 2026

I/O
(8)
Residential Condominium

NY

14.9

14.8

L+14.00%
(9)
19.1%

May 2021
(9)
I/O

Mixed-use

IL

14.5

14.3

L+12.25%

14.9%

Nov 2021

I/O

Residential Condominium

HI

11.5

11.5

14.00%

14.5%

Mar 2020
(10)
I/O

Office

CA

2.8

2.8

L+8.25%

10.2%

Nov 2021

I/O

Total/Weighted Average
 
 
 
$1,692.9
 
$1,682.5
 
 
 
6.8%
 
 
 
 
 
_______________________________________________________________________________

(1)
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 11 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected.
(2)
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of December 31, 2019 or the LIBOR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of December 31, 2019 as weighted by the outstanding principal balance of each loan.
(3)
Certain loans are subject to contractual extension options that generally vary between one and two 12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.
(4)
I/O = interest only, P/I = principal and interest.
(5)
In September 2019, the Company and the borrower entered into an extension agreement, which extended the maturity date on the senior Florida loan to February 2020.
(6)
In May 2019, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Michigan loan to July 2020.
(7)
In November 2019, the Company and the borrowers entered into a modification agreement to, among other things, waive certain performance hurdles associated with the borrowers’ business plan and increase the interest rate from a per annum rate of 12.00% to 13.00% on the senior California loan.
(8)
In February 2021, amortization will begin on the subordinated New Jersey loan, which had an outstanding principal balance of $17.0 million as of December 31, 2019. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.
(9)
In September 2019, the Company and the borrower entered into a modification agreement to, among other things, loan an additional $2.1 million to the borrower on the subordinated New York loan, for which such amount accrues interest at a per annum rate of 20.00% and has an initial maturity date of April 2020. The remaining outstanding principal balance of the subordinated New York loan continues to accrue interest at L + 14.00% and has an initial maturity date of May 2021.
(10)
In September 2019, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the subordinated Hawaii loan to March 2020.

The Company has made, and may continue to make, modifications to loans, including loans that are in default. Loan terms that may be modified include interest rates, required prepayments, asset release prices, maturity dates, covenants, principal amounts and other loan terms. The terms and conditions of each modification vary based on individual circumstances and will be determined on a case by case basis.
 
For the years ended December 31, 2019 and 2018, the activity in the Company’s loan portfolio was as follows ($ in thousands):

Balance at December 31, 2017
$
1,726,283

Initial funding
510,529

Origination fees and discounts, net of costs
(5,816
)
Additional funding
33,693

Amortizing payments
(645
)
Loan payoffs
(746,120
)
Origination fee accretion
6,949

Balance at December 31, 2018
$
1,524,873

Initial funding
493,913

Origination fees and discounts, net of costs
(7,539
)
Additional funding
185,281

Amortizing payments

Loan payoffs
(482,407
)
Loan converted to real estate owned (see Note 4)
(38,636
)
Origination fee accretion
7,013

Balance at December 31, 2019
$
1,682,498


As of December 31, 2019, all loans were paying in accordance with their contractual terms. No impairment charges have been recognized during the years ended December 31, 2019, 2018 and 2017.
v3.19.3.a.u2
REAL ESTATE OWNED
12 Months Ended
Dec. 31, 2019
Real Estate Owned [Abstract]  
Real Estate Owned
REAL ESTATE OWNED

On March 8, 2019, the Company acquired legal title to a hotel property located in New York through a deed in lieu of foreclosure. Prior to March 8, 2019, the hotel property collateralized a $38.6 million senior mortgage loan held by the Company that was in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the December 2018 maturity date. In conjunction with the deed in lieu of foreclosure, the Company derecognized the $38.6 million senior mortgage loan and recognized the hotel property as real estate owned. As the Company does not expect to complete a sale of the hotel property within the next twelve months, the hotel property is considered held for use, and is carried at its estimated fair value at acquisition and is presented net of accumulated depreciation and impairment charges. The Company did not recognize any gain or loss on the derecognition of the senior mortgage loan as the fair value of the hotel property of $36.9 million and the net assets held at the hotel property of $1.7 million at acquisition approximated the $38.6 million carrying value of the senior mortgage loan. The assets and liabilities of the hotel property are included within other assets and other liabilities, respectively, in the Company’s consolidated balance sheets and include items such as cash, restricted cash, trade receivables and payables and advance deposits.

The following table summarizes the Company’s real estate owned as of December 31, 2019 ($ in thousands):

 
December 31, 2019
Land
$
10,200

Buildings and improvements
24,281

Furniture, fixtures and equipment
4,087

 
38,568

Less: Accumulated depreciation
(667
)
Real estate owned, net
$
37,901



The Company did not have any real estate owned as of December 31, 2018.

As of December 31, 2019, no impairment charges have been recognized for real estate owned.

For the year ended December 31, 2019, the Company incurred depreciation expense of $667 thousand. Depreciation expense is included within expenses from real estate owned in the Company’s consolidated statements of operations.
v3.19.3.a.u2
DEBT
12 Months Ended
Dec. 31, 2019
Debt Disclosure [Abstract]  
DEBT
DEBT

Financing Agreements

The Company borrows funds, as applicable in a given period, under the Wells Fargo Facility, the Citibank Facility, the BAML Facility, the CNB Facility, the MetLife Facility and the U.S. Bank Facility (individually defined below and collectively, the “Secured Funding Agreements”), Notes Payable (as defined below) and the Secured Term Loan (as defined below). The Company refers to the Secured Funding Agreements, Notes Payable and the Secured Term Loan as the “Financing Agreements.” The outstanding balance of the Financing Agreements in the table below are presented gross of debt issuance costs. As of December 31, 2019 and 2018, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands):

 
As of December 31,
 
2019
 
2018
 
 
Outstanding Balance
 
Total
Commitment
 
Outstanding Balance
 
Total
Commitment
 
Wells Fargo Facility
$
360,354

 
$
500,000

 
$
274,071

 
$
500,000

 
Citibank Facility
126,603

 
325,000

 
184,003

 
325,000

 
BAML Facility
36,280

 
36,280

(1)
36,280

 
125,000

 
CNB Facility
30,500

 
50,000

(2)

 
50,000

 
MetLife Facility
131,807

 
180,000

 
135,145

 
180,000

 
U.S. Bank Facility
43,045

 
185,989

 
148,475

 
185,989

 
Notes Payable
56,155

 
84,155

 

 

 
Secured Term Loan
110,000

 
110,000

 
110,000

 
110,000

 
   Total
$
894,744

 
$
1,471,424

 
$
887,974

 
$
1,475,989

 
______________________________________________________________________________

(1)
In May 2019, the Company’s borrowing period for new individual loans under the BAML Facility (as defined below) expired and its term was not extended. As such, the total commitment amount under the BAML Facility as of December 31, 2019 represents the outstanding balance under the facility at the time the borrowing period expired, which was permitted to remain outstanding until September 2019, per the original terms of the BAML Facility. In September 2019, the Company amended the BAML Facility to extend the maturity date for the outstanding balance to December 4, 2019. In addition, in December 2019, the Company amended the BAML Facility to extend the maturity date for the outstanding balance to March 3, 2020.
    
(2)
In June 2019, the Company amended the CNB Facility (as defined below) to add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year.

Some of the Company’s Financing Agreements are collateralized by (i) assignments of specific loans, preferred equity or a pool of loans held for investment or loans held for sale owned by the Company, (ii) interests in the subordinated portion of the Company’s securitization debt, or (iii) interests in wholly-owned entity subsidiaries that hold the Company’s loans held for investment. The Company is the borrower or guarantor under each of the Financing Agreements. Generally, the Company partially offsets interest rate risk by matching the interest index of loans held for investment with the Secured Funding Agreements used to fund them. The Company’s Financing Agreements contain various affirmative and negative covenants, including negative pledges, and provisions regarding events of default that are normal and customary for similar financing arrangements.

Wells Fargo Facility
 
The Company is party to a master repurchase funding facility with Wells Fargo Bank, National Association (“Wells Fargo”) (the “Wells Fargo Facility”), which allows the Company to borrow up to $500.0 million. Under the Wells Fargo Facility, the Company is permitted to sell, and later repurchase, certain qualifying senior commercial mortgage loans, A-Notes, pari-passu participations in commercial mortgage loans and mezzanine loans under certain circumstances, subject to available collateral approved by Wells Fargo in its sole discretion. The initial maturity date of the Wells Fargo Facility is December 14, 2020, subject to three 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if all three were exercised, would extend the maturity date of the Wells Fargo Facility to December 14, 2023. Since December 14, 2018, advances under the Wells Fargo Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.50% to 2.25%. Prior to and including December 13, 2018, advances under the Wells Fargo Facility accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.75% to 2.35%. The Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the Wells Fargo Facility to the extent less than 75% of the Wells Fargo Facility is utilized. For the years ended December 31, 2019, 2018 and 2017, the Company incurred a non-utilization fee of $618 thousand, $149 thousand and $362 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

The Wells Fargo Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments in excess of the minimum amount necessary to continue to qualify as a REIT and avoid the payment of income and excise taxes, (d) maintenance of adequate capital, (e) limitations on change of control, (f) maintaining a ratio of total debt to tangible net worth of not more than 4.00 to 1.00, (g) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (h) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (i) maintaining a tangible net worth of at least the sum of (1) approximately $135.5 million, plus (2) 80% of the net proceeds raised in all future equity issuances by the Company and (j) if certain specific debt yield, loan to value or other credit based tests are not met with respect to assets on the Wells Fargo Facility, the Company may be required to repay certain amounts under the Wells Fargo Facility. As of December 31, 2019, the Company was in compliance with all financial covenants of the Wells Fargo Facility.
 
Citibank Facility

The Company is party to a $325.0 million master repurchase facility with Citibank, N.A. (“Citibank”) (the “Citibank Facility”). Under the Citibank Facility, the Company is permitted to sell and later repurchase certain qualifying senior commercial mortgage loans and A-Notes approved by Citibank in its sole discretion. The initial maturity date of the Citibank Facility is December 13, 2021, subject to two 12-month extensions, each of which may be exercised at the Company’s option assuming no existing defaults under the Citibank Facility and applicable extension fees being paid, which, if both were exercised, would extend the maturity date of the Citibank Facility to December 13, 2023. Since December 13, 2018, advances under the Citibank Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus an indicative pricing margin range of 1.50% to 2.25%, subject to certain exceptions. Prior to and including December 12, 2018, advances under the Citibank Facility accrued interest at a per annum rate equal to the sum of one-month LIBOR plus an indicative pricing margin range of 2.25% to 2.50%, subject to certain exceptions. Since December 13, 2018, the Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the Citibank Facility to the extent less than 75% of the Citibank Facility is utilized. Prior to and including December 12, 2018, the Company incurred a non-utilization fee of 25 basis points per annum on the average daily available balance of the Citibank Facility. For the years ended December 31, 2019, 2018 and 2017, the Company incurred a non-utilization fee of $388 thousand, $143 thousand and $165 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

The Citibank Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) maintaining tangible net worth of at least the sum of (1) 80% of the Company’s tangible net worth as of September 30, 2013, plus (2) 80% of the total net capital raised in all future equity issuances by the Company, (b) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity), (c) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (d) maintaining a ratio of total debt to tangible net worth of not more than 4.00 to 1.00, (e) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00 and (f) if certain specific debt yield and loan to value tests are not met with respect to assets on the Citibank Facility, the Company may be required to repay certain amounts under the Citibank Facility. The Citibank Facility also prohibits the Company from amending the management agreement with its Manager in a material respect without the prior consent of the lender. As of December 31, 2019, the Company was in compliance with all financial covenants of the Citibank Facility.

BAML Facility

The Company is party to a $125.0 million Bridge Loan Warehousing Credit and Security Agreement with Bank of America, N.A. (“Bank of America”) (the “BAML Facility”). Under the BAML Facility, the Company may obtain advances secured by eligible commercial mortgage loans collateralized by multifamily properties. Bank of America may approve the loans on which advances are made under the BAML Facility in its sole discretion. The Company was able to request individual loans under the facility up to May 23, 2019 and the term of the borrowing period was not extended. Individual advances under the BAML Facility had a two-year maturity, subject to one 12-month extension at the Company’s option upon the satisfaction of certain conditions and applicable extension fees being paid. As of December 31, 2019, the Company had one individual advance outstanding in the amount of $36.3 million that had a maturity date of September 5, 2019 per the original terms of the BAML Facility. In September 2019, the Company amended the BAML Facility to extend the maturity date for the one individual advance outstanding to December 4, 2019. In addition, in December 2019, the Company amended the BAML Facility to extend the maturity date for the one individual advance outstanding to March 3, 2020. Since October 2, 2017, advances under the BAML Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.00%, subject to certain exceptions. Prior to and including October 1, 2017, advances under the BAML Facility accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread ranging from 2.25% to 2.75% depending upon the type of asset securing such advance. The Company incurred a non-utilization fee of 12.5 basis points per annum up to May 23, 2019 on the average daily available balance of the BAML Facility to the extent less than 50% of the BAML Facility was utilized. For the years ended December 31, 2019, 2018 and 2017, the Company incurred a non-utilization fee of $43 thousand, $21 thousand and $52 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

The BAML Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar financing facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default, (d) limitations on dispositions of assets and (e) prohibitions of certain change of control events.  The agreements governing the BAML Facility also impose certain covenants on the Company, including the following: (i) maintaining a ratio of total debt to tangible net worth of not more than 4.00 to 1.00, (ii) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (iii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2013, plus 80% of the net cash proceeds raised in equity issuances by the Company after September 30, 2013, (iv) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period of at least 1.25 to 1.00, (v) limitations on mergers, consolidations, transfers of assets and similar transactions and (vi) maintaining its status as a REIT. As of December 31, 2019, the Company was in compliance with all financial covenants of the BAML Facility.

CNB Facility

The Company is party to a $50.0 million secured revolving funding facility with City National Bank (the “CNB Facility”). The Company is permitted to borrow funds under the CNB Facility to finance investments and for other working capital and general corporate needs. The initial maturity date of the CNB Facility is March 11, 2020. In June 2019, the Company amended the CNB Facility to, among other things, (1) add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year, (2) add two additional 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the CNB Facility to March 10, 2022 and (3) decrease the interest rate on advances to a per annum rate equal to the sum of, at the Company’s option, either (a) LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 2.65% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.00%; provided that in no event shall the interest rate be less than 2.65%. Previously, the interest rate on advances was a per annum rate equal to the sum of, at the Company’s option, either (a) LIBOR for a one, two, three, six or, if available to all lenders, 12-month interest period plus 3.00% or (b) a base rate (which is the highest of a prime rate, the federal funds rate plus 0.50%, or one-month LIBOR plus 1.00%) plus 1.25%. Unless at least 75% of the CNB Facility is used on average, unused commitments under the CNB Facility accrue non-utilization fees at the rate of 0.375% per annum. For the years ended December 31, 2019, 2018 and 2017, the Company incurred a non-utilization fee of $136 thousand, $166 thousand and $184 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.
    
The CNB Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar financing facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default, (d) limitations on dispositions of assets, (e) maintenance of minimum total asset value by the borrower under the CNB Facility and its subsidiaries and (f) prohibitions of certain change of control events.  The agreements governing the CNB Facility also impose certain covenants on the Company, including the following: (i) maintaining a ratio of total debt to tangible net worth of not more than 4.00 to 1.00, (ii) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (iii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2013, plus 80% of the net cash proceeds raised in equity issuances by the Company after March 12, 2014, (iv) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period of at least 1.25 to 1.00, (v) limitations on mergers, consolidations, transfers of assets and similar transactions and (vi) maintaining its status as a REIT. As of December 31, 2019, the Company was in compliance with all financial covenants of the CNB Facility.
    
MetLife Facility    

The Company and certain of its subsidiaries are party to a $180.0 million revolving master repurchase facility with Metropolitan Life Insurance Company (“MetLife”) (the “MetLife Facility”), pursuant to which the Company may sell, and later repurchase, commercial mortgage loans meeting defined eligibility criteria which are approved by MetLife in its sole discretion. The initial maturity date of the MetLife Facility is August 12, 2020, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the MetLife Facility to August 12, 2022. Since August 4, 2017, advances under the MetLife Facility accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.30%. Prior to and including August 3, 2017, advances under the MetLife Facility accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.35%. Effective in February 2018, the Company began incurring a non-utilization fee of 25 basis points per annum on the average daily available balance of the MetLife Facility to the extent less than 65% of the MetLife Facility is utilized. For the years ended December 31, 2019 and 2018, the Company incurred a non-utilization fee of $5 thousand and $7 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

The MetLife Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default and (d) limitations on dispositions of assets.  The agreements governing the MetLife Facility also impose certain covenants on the Company, including the following: (i) maintaining a ratio of total debt to tangible net worth of not more than 4.00 to 1.00, (ii) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (iii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2013, plus 80% of the net cash proceeds raised in equity issuances by the Company after August 13, 2014, (iv) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period of at least 1.25 to 1.00, and (v) if certain specific debt yield, loan to value or other credit based tests are not met with respect to assets on the MetLife Facility, the Company may be required to repay certain amounts under the MetLife Facility. As of December 31, 2019, the Company was in compliance with all financial covenants of the MetLife Facility.

U.S. Bank Facility

The Company and certain of its subsidiaries are party to a $186.0 million master repurchase and securities contract with U.S. Bank National Association (“U.S. Bank”) (the “U.S. Bank Facility”). Pursuant to the U.S. Bank Facility, the Company is permitted to sell, and later repurchase, eligible commercial mortgage loans collateralized by retail, office, mixed-use, multifamily, industrial, hospitality, student housing, manufactured housing or self storage properties. U.S. Bank may approve the mortgage loans that are subject to the U.S. Bank Facility in its sole discretion. The initial maturity date of the U.S. Bank Facility is July 31, 2020, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the U.S. Bank Facility to July 31, 2022. Advances under the U.S. Bank Facility generally accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.25%, unless otherwise agreed between U.S. Bank and the Company, depending upon the mortgage loan sold to U.S. Bank in the applicable transaction. The Company incurs a non-utilization fee of 25 basis points per annum on the average daily available balance of the U.S. Bank Facility to the extent less than 50% of the U.S. Bank Facility is utilized. For the years ended December 31, 2019 and 2017, the Company incurred a non-utilization fee of $246 thousand and $83 thousand, respectively. For the year ended December 31, 2018, the Company did not incur a non-utilization fee. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations.

The U.S. Bank Facility contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar repurchase facilities, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments in excess of the minimum amount necessary to continue to qualify as a REIT and avoid the payment of income and excise taxes, (d) maintenance of adequate capital, (e) limitations on change of control, (f) maintaining a ratio of total debt to tangible net worth of not more than 4.00 to 1.00, (g) maintaining a ratio of recourse debt to tangible net worth of not more than 3.00 to 1.00, (h) maintaining a fixed charge coverage ratio (expressed as the ratio of EBITDA (net income before net interest expense, income tax expense, depreciation and amortization), as defined, to fixed charges) for the immediately preceding 12-month period ending on the last date of the applicable reporting period to be at least 1.25 to 1.00, (i) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2013, plus 80% of the net cash proceeds raised in equity issuances by the Company after September 30, 2013, (j) if certain specific debt yield, loan to value or other credit based tests are not met with respect to assets on the U.S. Bank Facility, the Company may be required to repay certain amounts under the U.S. Bank Facility and (k) maintaining liquidity in an amount not less than the greater of (1) $5.0 million or (2) 5% of the Company’s recourse indebtedness, not to exceed $10.0 million (provided that in the event the Company’s total liquidity equals or exceeds $5.0 million, the Company may satisfy the difference between the minimum total liquidity requirement and the Company’s total liquidity with available borrowing capacity). As of December 31, 2019, the Company was in compliance with all financial covenants of the U.S. Bank Facility.

Notes Payable

Certain of the Company’s subsidiaries are party to three separate non-recourse note agreements (collectively, the “Notes Payable”) with the lenders referred to therein, consisting of (1) a $32.4 million note that was closed in May 2019, which is secured by a $40.5 million senior mortgage loan held by the Company on an industrial property located in North Carolina, (2) a $28.3 million note that was closed in June 2019, which is secured by a hotel property located in New York that is recognized as real estate owned in the Company’s consolidated balance sheets and (3) a $23.5 million note that was closed in November 2019, which is secured by a $34.6 million senior mortgage loan held by the Company on a multifamily property located in South Carolina.

The initial maturity date of the $32.4 million note is March 5, 2024, subject to one 12-month extension, which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if exercised, would extend the maturity date to March 5, 2025. Advances under the $32.4 million note accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.50%. As of December 31, 2019, the total outstanding principal balance of the note was $27.9 million.

The maturity date of the $28.3 million note is June 10, 2024. The loan may be prepaid at any time subject to the payment of a prepayment fee, if applicable. Initial advances under the $28.3 million note accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 3.00%. If the hotel property that collateralizes the $28.3 million note achieves certain financial performance hurdles, the interest rate on advances will decrease to a per annum rate equal to the sum of one-month LIBOR plus a spread of 2.50%. The $28.3 million loan amount may be increased to up to $30.0 million to fund certain construction costs of improvements at the hotel, subject to the satisfaction of certain conditions and the payment of a commitment fee. As of December 31, 2019, the total outstanding principal balance of the note was $28.3 million.

The initial maturity date of the $23.5 million note is September 5, 2022, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date to September 5, 2024. Advances under the $23.5 million note accrue interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 3.75%. As of December 31, 2019, there was no outstanding principal balance on the note.

Secured Term Loan

The Company and certain of its subsidiaries are party to a $110.0 million Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”). The initial maturity date of the Secured Term Loan is December 22, 2020, subject to one 12-month extension, which may be exercised at the Company’s option, provided there are no existing events of default under the Secured Term Loan, which, if exercised, would extend the maturity date of the Secured Term Loan to December 22, 2021. During the extension period, the spread on advances under the Secured Term Loan increases every three months by 0.125%, 0.375% and 0.750% per annum, respectively, beginning after the third-month of the extension period. Since December 22, 2017, advances under the Secured Term Loan accrue interest at a per annum rate equal to the sum of, at the Company’s option, one, two, three or six-month LIBOR plus a spread of 5.00%. Prior to and including December 21, 2017, advances under the Secured Term Loan accrued interest at a per annum rate equal to the sum of one-month LIBOR plus a spread of 6.00% (with a 1.00% LIBOR floor). In December 2017, the Company voluntarily elected to repay $45.0 million of outstanding principal on the Secured Term Loan prior to the scheduled maturity as permitted by the contractual terms of the Secured Term Loan. For the year ended December 31, 2017, the Company incurred early extinguishment of debt costs of $768 thousand in connection with the $45.0 million repayment of outstanding principal on the Secured Term Loan, which was comprised of the pro-rata share of the unamortized deferred debt issuance costs and original issue discounts being allocated to the outstanding principal that was repaid. The costs are included within early extinguishment of debt costs in the Company’s consolidated statements of operations.

The total original issue discount on the Secured Term Loan draws was $2.6 million, which represents a discount to the debt cost to be amortized into interest expense using the effective interest method over the term of the Secured Term Loan. For the years ended December 31, 2019 and 2018, the estimated per annum effective interest rate of the Secured Term Loan, which is equal to LIBOR plus the spread plus the accretion of the original issue discount and associated costs, was 8.0% and 7.6%, respectively. For the year ended December 31, 2017, the estimated per annum effective interest rate of the Secured Term Loan was 8.7% prior to and including December 21, 2017 and 7.2% subsequent to December 21, 2017.
        
The Company's obligations under the Secured Term Loan are guaranteed by certain subsidiaries of the Company. Certain subsidiaries of the Company entered into a Pledge and Security Agreement with the collateral agent under the Secured Term Loan, pursuant to which the obligations of the Company and the subsidiary guarantors under the Secured Term Loan are each secured by equity interests in certain of the Company's indirect subsidiaries and other assets. In addition, the Company and certain of its subsidiaries entered into a Negative Pledge Agreement with the collateral agent under the Secured Term Loan, which prohibits pledging or otherwise encumbering, subject to permitted encumbrances, certain of the assets which were not subject to the Pledge and Security Agreement.

The Secured Term Loan contains various affirmative and negative covenants and provisions regarding events of default that are applicable to the Company and certain of the Company’s subsidiaries, which are normal and customary for similar financing agreements, including the following: (a) limitations on the incurrence of additional indebtedness or liens, (b) limitations on how borrowed funds may be used, (c) limitations on certain distributions and dividend payments following a default or event of default, (d) limitations on dispositions of assets and (e) prohibitions of certain change of control events. The agreements governing the Secured Term Loan also impose certain covenants on the Company, including the following: (i) maintaining a ratio of total debt to tangible net worth of not more than 4.00 to 1.00, (ii) maintaining a tangible net worth of at least 80% of the Company’s net worth as of September 30, 2015, plus 80% of the net cash proceeds raised in subsequent equity issuances by the Company, (iii) maintaining an asset coverage ratio greater than 110%, (iv) maintaining an unencumbered asset ratio greater than 120%, (v) limitations on mergers, consolidations, transfers of assets and similar transactions, (vi) maintaining its status as a REIT and (vii) maintaining at least 65% of loans held for investment as senior commercial real estate loans, as measured by the average daily outstanding principal balance of all loans held for investment during a fiscal quarter and as adjusted for non-controlling interests. As of December 31, 2019, the Company was in compliance with all financial covenants of the Secured Term Loan.
 
Financing Agreements Maturities

At December 31, 2019, approximate principal maturities of the Company’s Financing Agreements are as follows ($ in thousands):


Wells Fargo
Facility
 
Citibank
Facility
 
BAML Facility
 
CNB
Facility
 
MetLife Facility
 
U.S. Bank Facility
 
Notes Payable
 
Secured Term Loan
 
Total
2020
$
360,354

 
$

 
$
36,280

 
$
30,500

 
$
131,807

 
$
43,045

 
$

 
$
110,000

 
$
711,986

2021

 
126,603

 

 

 

 

 

 

 
126,603

2022

 

 

 

 

 

 

 

 

2023

 

 

 

 

 

 

 

 

2024

 

 

 

 

 

 
56,155

 

 
56,155

Thereafter

 

 

 

 

 

 

 

 


$
360,354

 
$
126,603

 
$
36,280

 
$
30,500

 
$
131,807

 
$
43,045

 
$
56,155

 
$
110,000

 
$
894,744

v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES

As of December 31, 2019 and 2018, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands):
 
As of December 31,
 
2019
 
2018
Total commitments
$
1,909,084

 
$
1,677,615

Less: funded commitments
(1,692,894
)
 
(1,534,743
)
Total unfunded commitments
$
216,190

 
$
142,872



The Company from time to time may be a party to litigation relating to claims arising in the normal course of business. As of December 31, 2019, the Company is not aware of any legal claims that could materially impact its business, financial condition or results of operations.
v3.19.3.a.u2
STOCKHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY
STOCKHOLDERS’ EQUITY

At the Market Stock Offering Program

On November 22, 2019, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”), pursuant to which the Company may offer and sell, from time to time, shares of the Company’s common stock, par value $0.01 per share, having an aggregate offering price of up to $100.0 million. Subject to the terms and conditions of the Equity Distribution Agreement, sales of common stock, if any, may be made in transactions that are deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended. During the year ended December 31, 2019, the Company did not issue or sell any shares of common stock under the Equity Distribution Agreement.

Common Stock

There were no shares issued in public or private offerings for the years ended December 31, 2019, 2018 and 2017. See “Equity Incentive Plan” below for shares issued under the plan.

Equity Incentive Plan
 
On April 23, 2012, the Company adopted an equity incentive plan. In April 2018, the Company’s board of directors authorized, and in June 2018, the Company’s stockholders approved, an amended and restated equity incentive plan that increased the total amount of shares of common stock the Company may grant thereunder to 1,390,000 shares (the “Amended and Restated 2012 Equity Incentive Plan”). Pursuant to the Amended and Restated 2012 Equity Incentive Plan, the Company may grant awards consisting of restricted shares of the Company’s common stock, RSUs and/or other equity-based awards to the Company’s outside directors, employees of the Manager, officers, ACREM and other eligible awardees under the plan. Any restricted shares of the Company’s common stock and RSUs will be accounted for under FASB ASC Topic 718, Compensation—Stock Compensation, resulting in stock-based compensation expense equal to the grant date fair value of the underlying restricted shares of common stock or RSUs.
 
Restricted stock and RSU grants generally vest ratably over a one to four year period from the vesting start date. The grantee receives additional compensation for each outstanding restricted stock or RSU grant, classified as dividends paid, equal to the per-share dividends received by common stockholders.

The following table details the restricted stock and RSU grants awarded as of December 31, 2019:

Grant Date
 
Vesting Start Date
 
Shares Granted
 
May 1, 2012
 
July 1, 2012
 
35,135

 
June 18, 2012
 
July 1, 2012
 
7,027

 
July 9, 2012
 
October 1, 2012
 
25,000

 
June 26, 2013
 
July 1, 2013
 
22,526

 
November 25, 2013
 
November 25, 2016
 
30,381

 
January 31, 2014
 
August 31, 2015
 
48,273

 
February 26, 2014
 
February 26, 2014
 
12,030

 
February 27, 2014
 
August 27, 2014
 
22,354

 
June 24, 2014
 
June 24, 2014
 
17,658

 
June 24, 2015
 
July 1, 2015
 
25,555

 
April 25, 2016
 
July 1, 2016
 
10,000

 
June 27, 2016
 
July 1, 2016
 
24,680

 
April 25, 2017
 
April 25, 2018
 
81,710

 
June 7, 2017
 
July 1, 2017
 
18,224

 
October 17, 2017
 
January 2, 2018
 
7,278

 
December 15, 2017
 
January 2, 2018
 
8,948

 
May 14, 2018
 
July 2, 2018
 
31,766

 
June 26, 2018
 
July 1, 2019
 
67,918

 
December 14, 2018
 
March 31, 2019
 
57,065

 
March 7, 2019
 
April 1, 2020
 
102,300

 
April 23, 2019
 
July 1, 2019
 
19,665

 
December 20, 2019
 
March 31, 2020
 
61,594

(1)
Total
 
 
 
737,087

 

______________________________________________________________________________

(1)    Represents an RSU grant.

The following tables summarize the (i) non-vested shares of restricted stock and RSUs and (ii) vesting schedule of shares of restricted stock and RSUs for the Company’s directors and officers and employees of the Manager as of December 31, 2019:

Schedule of Non-Vested Share and Share Equivalents

 
 Restricted Stock Grants—Directors
 
Restricted Stock Grants—Officers and Employees of the Manager
 
RSUs—Officers and Employees of the Manager
 
Total
Balance at December 31, 2018
22,554

 
179,456

 

 
202,010

Granted
19,665

 
102,300

 
61,594

 
183,559

Vested
(25,853
)
 
(62,303
)
 

 
(88,156
)
Forfeited
(4,034
)
 
(7,986
)
 

 
(12,020
)
Balance at December 31, 2019
12,332

 
211,467

 
61,594

 
285,393



Future Anticipated Vesting Schedule

 
Restricted Stock Grants—Directors
 
Restricted Stock Grants—Officers and Employees of the Manager
 
RSUs—Officers and Employees of the Manager
 
Total
2020
11,498

 
96,752

 
9,944

 
118,194

2021
834

 
69,510

 
17,222

 
87,566

2022

 
45,205

 
17,219

 
62,424

2023

 

 
17,209

 
17,209

2024

 

 

 

Total
12,332

 
211,467

 
61,594

 
285,393


The following table summarizes the restricted stock and RSU compensation expense included within general and administrative expenses in the Company’s consolidated statements of operations, the total fair value of shares vested and the weighted average grant date fair value of the restricted stock and RSUs granted to the Company’s directors and officers and employees of the Manager for the years ended December 31, 2019, 2018 and 2017 ($ in thousands):
 
For the years ended December 31,
 
2019
 
2018
 
2017
 
Restricted Stock and RSU Grants
 
Restricted Stock Grants
 
Restricted Stock Grants
 
Directors
 
Officers and Employees of the Manager
 
Total
 
Directors
 
Officers and Employees of the Manager
 
Total
 
Directors
 
Officers and Employees of the Manager
 
Total
Compensation expense
$
343

 
$
1,537

 
$
1,880

 
$
427

 
$
675

 
$
1,102

 
$
317

 
$
264

 
$
581

Total fair value of shares vested (1)
373

 
939

 
1,312

 
405

 
449

 
854

 
347

 

 
347

Weighted average grant date fair value
302

 
2,527

 
2,829

 
427

 
1,759

 
2,186

 
338

 
1,254

 
1,592

______________________________________________________________________________

(1)    Based on the closing price of the Company’s common stock on the NYSE on each vesting date.

As of December 31, 2019, 2018 and 2017, the total compensation cost related to non-vested awards not yet recognized totaled $3.1 million, $2.3 million and $1.2 million, respectively, and the weighted average period over which the non-vested awards are expected to be recognized is 2.3 years, 2.1 years and 1.9 years, respectively.
v3.19.3.a.u2
EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
EARNINGS PER SHARE

The following information sets forth the computations of basic and diluted earnings per common share for the years ended December 31, 2019, 2018 and 2017 ($ in thousands, except share and per share data):

 
For the years ended December 31,
 
2019
 
2018
 
2017
Net income attributable to common stockholders
$
36,991

 
$
38,596

 
$
30,407

Divided by:
 
 


 


Basic weighted average shares of common stock outstanding:
28,609,282

 
28,529,439

 
28,478,237

Weighted average non-vested restricted stock and RSUs
237,359

 
127,221

 
72,708

Diluted weighted average shares of common stock outstanding:
28,846,641

 
28,656,660

 
28,550,945

Basic earnings per common share
$
1.29

 
$
1.35

 
$
1.07

Diluted earnings per common share
$
1.28

 
$
1.35

 
$
1.07

v3.19.3.a.u2
INCOME TAX
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
INCOME TAX
INCOME TAX

The Company wholly-owns ACRC Lender W TRS LLC, which is a TRS formed to issue and hold certain loans intended for sale. The Company also wholly-owns ACRC 2017-FL3 TRS LLC, which is a TRS formed to hold a portion of the CLO Securitization (as defined below), including the portion that generates excess inclusion income. Additionally, the Company wholly-owns ACRC WM Tenant LLC, which is a TRS formed to lease from an affiliate the hotel property classified as real estate owned acquired on March 8, 2019. ACRC WM Tenant LLC engaged a third-party hotel management company to operate the hotel under a management contract.

The income tax provision for the Company and the TRSs consisted of the following for the years ended December 31, 2019, 2018 and 2017 ($ in thousands):

 
For the years ended December 31,
 
2019
 
2018
 
2017
Current
$
114

 
$
84

 
$
25

Deferred
99

 

 

Excise tax
302

 
362

 
153

   Total income tax expense, including excise tax
$
515

 
$
446

 
$
178



For the years ended December 31, 2019, 2018 and 2017, the Company incurred an expense of $302 thousand, $362 thousand and $153 thousand, respectively, for United States federal excise tax. Excise tax represents a 4% tax on the sum of a portion of the Company’s ordinary income and net capital gains not distributed during the calendar year (including any distribution declared in the fourth quarter and paid following January) plus any prior year shortfall. If it is determined that an excise tax liability exists for the current year, the Company will accrue excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations.

The TRSs recognize interest and penalties related to unrecognized tax benefits within income tax expense in the Company’s consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the Company’s consolidated balance sheets.

As of December 31, 2019, tax years 2016 through 2019 remain subject to examination by taxing authorities. The Company does not have any unrecognized tax benefits and the Company does not expect that to change in the next 12 months.
v3.19.3.a.u2
FAIR VALUE
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
FAIR VALUE
FAIR VALUE

The Company follows FASB ASC Topic 820-10, Fair Value Measurement (“ASC 820-10”), which expands the application of fair value accounting. ASC 820-10 defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosure requirements for fair value measurements. ASC 820-10 determines fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. ASC 820-10 specifies a hierarchy of valuation techniques based on the inputs used in measuring fair value.

In accordance with ASC 820-10, the inputs used to measure fair value are summarized in the three broad levels listed below:

Level 1-Quoted prices in active markets for identical assets or liabilities.

Level 2-Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.

Level 3-Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.

GAAP requires disclosure of fair value information about financial and nonfinancial assets and liabilities, whether or not recognized in the financial statements, for which it is practical to estimate the value. In cases where quoted market prices are not available, fair values are based upon the application of discount rates to estimated future cash flows using market yields, or other valuation methodologies. Any changes to the valuation methodology will be reviewed by the Company’s management to ensure the changes are appropriate. The methods used may produce a fair value calculation that is not indicative of net realizable value or reflective of future fair values.  Furthermore, while the Company anticipates that the valuation methods are appropriate and consistent with other market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial and nonfinancial assets and liabilities could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may fall within periods of market dislocation, during which price transparency may be reduced.

As of December 31, 2019 and 2018, the Company did not have any financial and nonfinancial assets or liabilities required to be recorded at fair value on a recurring basis.

Nonrecurring Fair Value Measurements

The Company is required to record real estate owned, a nonfinancial asset, at fair value on a nonrecurring basis in accordance with GAAP. Real estate owned consists of a hotel property that was acquired by the Company on March 8, 2019 through a deed in lieu of foreclosure. See Note 4 included in these consolidated financial statements for more information on real estate owned. Real estate owned is recorded at fair value at acquisition using Level 3 inputs and is evaluated for indicators of impairment on a quarterly basis. Real estate owned is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate owned over the estimated remaining holding period is less than the carrying amount of such real estate owned. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate owned. An impairment charge is recorded equal to the excess of the carrying value of the real estate owned over the fair value. The fair value of the hotel property at acquisition was estimated using a third-party appraisal, which utilized standard industry valuation techniques such as the income and market approach. When determining the fair value of a hotel, certain assumptions are made including, but not limited to: (1) projected operating cash flows, including factors such as booking pace, growth rates, occupancy, daily room rates, hotel specific operating costs and future capital expenditures; and (2) projected cash flows from the eventual disposition of the hotel based upon the Company’s estimation of a hotel specific capitalization rate, hotel specific discount rates and comparable selling prices in the market.

As of December 31, 2018, the Company did not have any nonfinancial assets required to be recorded at fair value on a nonrecurring basis. In addition, as of December 31, 2019 and 2018, the Company did not have any financial assets or liabilities or nonfinancial liabilities required to be recorded at fair value on a nonrecurring basis.

Financial Assets and Liabilities Not Measured at Fair Value

As of December 31, 2019 and 2018, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands):

 
 
 
As of December 31,
 
 
 
2019
 
2018
 
Level in Fair Value Hierarchy
 
Carrying Value
 
Fair
Value
 
Carrying Value
 
Fair
Value
Financial assets:
 
 
 
 
 
 
 
 
 
   Loans held for investment
3
 
$
1,682,498

 
$
1,692,894

 
$
1,524,873

 
$
1,534,743

Financial liabilities:
 
 
 
 
 
 
 
 
 
   Secured funding agreements
2
 
$
728,589

 
$
728,589

 
$
777,974

 
$
777,974

   Notes payable
2
 
54,708

 
56,155

 

 

   Secured term loan
2
 
109,149

 
110,000

 
108,345

 
110,000

Collateralized loan obligation securitization debt (consolidated VIE)
3
 
443,177

 
445,600

 
270,737

 
272,927



The carrying values of cash and cash equivalents, restricted cash, interest receivable, due to affiliate liability and accrued expenses, which are all categorized as Level 2 within the fair value hierarchy, approximate their fair values due to their short-term nature.
     
Loans held for investment are recorded at cost, net of unamortized loan fees and origination costs and net of an allowance for loan losses. The Company may record fair value adjustments on a nonrecurring basis when it has determined that it is necessary to record a specific reserve against a loan and the Company measures such specific reserve using the fair value of the loan’s collateral. To determine the fair value of the collateral, the Company may employ different approaches depending on the type of collateral. The Financing Agreements and collateralized loan obligation (“CLO”) securitization debt are recorded at outstanding principal, which is the Company’s best estimate of the fair value.
v3.19.3.a.u2
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2019
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS

Management Agreement

The Company is party to a Management Agreement under which ACREM, subject to the supervision and oversight of the Company’s board of directors, is responsible for, among other duties, (a) performing all of the Company’s day-to-day functions, (b) determining the Company’s investment strategy and guidelines in conjunction with the Company’s board of directors, (c) sourcing, analyzing and executing investments, asset sales and financing, and (d) performing portfolio management duties. In addition, ACREM has an Investment Committee that oversees compliance with the Company’s investment strategy and guidelines, loans held for investment portfolio holdings and financing strategy.
 
In exchange for its services, ACREM is entitled to receive a base management fee, an incentive fee and expense reimbursements. In addition, ACREM and its personnel may receive grants of equity-based awards pursuant to the Company’s Amended and Restated 2012 Equity Incentive Plan and a termination fee, if applicable.
 
The base management fee is equal to 1.5% of the Company’s stockholders’ equity per annum, which is calculated and payable quarterly in arrears in cash. For purposes of calculating the base management fee, stockholders’ equity means: (a) the sum of (i) the net proceeds from all issuances of the Company’s equity securities since inception (allocated on a pro-rata daily basis for such issuances during the fiscal quarter of any such issuance), plus (ii) the Company’s retained earnings at the end of the most recently completed fiscal quarter determined in accordance with GAAP (without taking into account any non-cash equity compensation expense incurred in current or prior periods); less (b) (x) any amount that the Company has paid to repurchase the Company’s common stock since inception, (y) any unrealized gains and losses and other non-cash items that have impacted stockholders’ equity as reported in the Company’s consolidated financial statements prepared in accordance with GAAP, and (z) one-time events pursuant to changes in GAAP, and certain non-cash items not otherwise described above, in each case after discussions between ACREM and the Company’s independent directors and approval by a majority of the Company’s independent directors. As a result, the Company’s stockholders’ equity, for purposes of calculating the management fee, could be greater or less than the amount of stockholders’ equity shown in the Company’s consolidated financial statements.
 
The incentive fee is an amount, not less than zero, equal to the difference between: (a) the product of (i) 20% and (ii) the difference between (A) the Company’s Core Earnings (as defined below) for the previous 12-month period, and (B) the product of (1) the weighted average of the issue price per share of the Company’s common stock of all of the Company’s public offerings of common stock multiplied by the weighted average number of all shares of common stock outstanding including any restricted shares of the Company’s common stock, restricted stock units or any shares of the Company’s common stock not yet issued, but underlying other awards granted under the Company’s Amended and Restated 2012 Equity Incentive Plan (see Note 7 included in these consolidated financial statements) in the previous 12-month period, and (2) 8%; and (b) the sum of any incentive fees earned by ACREM with respect to the first three fiscal quarters of such previous 12-month period; provided, however, that no incentive fee is payable with respect to any fiscal quarter unless cumulative Core Earnings for the 12 most recently completed fiscal quarters is greater than zero. “Core Earnings” is a non-GAAP measure and is defined as GAAP net income (loss) computed in accordance with GAAP, excluding non-cash equity compensation expense, the incentive fee, depreciation and amortization (to the extent that any of the Company’s target investments are structured as debt and the Company forecloses on any properties underlying such debt), any unrealized gains, losses or other non-cash items recorded in net income (loss) for the period, regardless of whether such items are included in other comprehensive income or loss, or in net income (loss), and one-time events pursuant to changes in GAAP and certain non-cash charges after discussions between ACREM and the Company’s independent directors and after approval by a majority of the Company’s independent directors. For the years ended December 31, 2019, 2018 and 2017, the Company incurred incentive fees of $1.1 million, $1.2 million and $381 thousand, respectively.
 
The Company reimburses ACREM at cost for operating expenses that ACREM incurs on the Company’s behalf, including expenses relating to legal, financial, accounting, servicing, due diligence and other services, expenses in connection with the origination and financing of the Company’s investments, communications with the Company’s stockholders, information technology systems, software and data services used for the Company, travel, complying with legal and regulatory requirements, taxes, insurance maintained for the benefit of the Company as well as all other expenses actually incurred by ACREM that are reasonably necessary for the performance by ACREM of its duties and functions under the Management Agreement. Ares Management, from time to time, incurs fees, costs and expenses on behalf of more than one investment vehicle. To the extent such fees, costs and expenses are incurred for the account or benefit of more than one fund, each such investment vehicle, including the Company, will typically bear an allocable portion of any such fees, costs and expenses in proportion to the size of its investment in the activity or entity to which such expense relates (subject to the terms of each fund’s governing documents) or in such other manner as Ares Management considers fair and equitable under the circumstances, such as the relative fund size or capital available to be invested by such investment vehicles. Where an investment vehicle’s governing documents do not permit the payment of a particular expense, Ares Management will generally pay such investment vehicle’s allocable portion of such expense. In addition, the Company is responsible for its proportionate share of certain fees and expenses, including due diligence costs, as determined by ACREM and Ares Management, including legal, accounting and financial advisor fees and related costs, incurred in connection with evaluating and consummating investment opportunities, regardless of whether such transactions are ultimately consummated by the parties thereto.

 The Company will not reimburse ACREM for the salaries and other compensation of its personnel, except for the allocable share of the salaries and other compensation of the Company’s (a) Chief Financial Officer, based on the percentage of his time spent on the Company’s affairs and (b) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of ACREM or its affiliates who spend all or a portion of their time managing the Company’s affairs based on the percentage of their time spent on the Company’s affairs. The Company is also required to pay its pro-rata portion of rent, telephone, utilities, office furniture, equipment, machinery and other office, internal and overhead expenses of ACREM and its affiliates that are required for the Company’s operations.
 
Certain of the Company’s subsidiaries, along with the Company’s lenders under certain of the Company’s Secured Funding Agreements, as well as under the CLO transaction have entered into various servicing agreements with ACREM’s subsidiary servicer, Ares Commercial Real Estate Servicer LLC (“ACRES”). The Company’s Manager will specially service, as needed, certain of the Company’s investments. Effective May 1, 2012, ACRES agreed that no servicing fees pursuant to these servicing agreements would be charged to the Company or its subsidiaries by ACRES or the Manager for so long as the Management Agreement remains in effect, but that ACRES will continue to receive reimbursement for overhead related to servicing and operational activities pursuant to the terms of the Management Agreement.

The term of the Management Agreement ends on May 1, 2020, with automatic one-year renewal terms thereafter. Except under limited circumstances, upon a termination of the Management Agreement, the Company will pay ACREM a termination fee equal to three times the average annual base management fee and incentive fee received by ACREM during the 24-month period immediately preceding the most recently completed fiscal quarter prior to the date of termination, each as described above.
  
The following table summarizes the related party costs incurred by the Company for the years ended December 31, 2019, 2018 and 2017 and amounts payable to the Company’s Manager as of December 31, 2019 and 2018 ($ in thousands):

 
Incurred
 
Payable
 
For the years ended December 31,
 
As of December 31,
 
2019
 
2018
 
2017
 
2019
 
2018
Affiliate Payments
 
 
 
 
 
 
 
 
 
Management fees
$
6,311

 
$
6,268

 
$
6,188

 
$
1,581

 
$
1,576

Incentive fees
1,052

 
1,150

 
381

 
378

 
540

General and administrative expenses
3,026

 
3,570

 
3,899

 
789

 
996

Direct costs (1)
192

 
224

 
304

 
13

 
51

Total
$
10,581

 
$
11,212

 
$
10,772

 
$
2,761

 
$
3,163

______________________________________________________________________________

(1)
For the years ended December 31, 2019, 2018 and 2017, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.

Investments in Loans

From time to time, the Company may co-invest with other investment vehicles managed by Ares Management or its affiliates, including the Manager, and their portfolio companies, including by means of splitting investments, participating in investments or other means of syndication of investments. For such co-investments, the Company expects to act as the administrative agent for the holders of such investments provided that the Company maintains a majority of the aggregate investment. No fees will be received by the Company for performing such service. The Company will be responsible for its pro-rata share of costs and expenses for such co-investments, including due diligence costs for transactions which fail to close. The Company’s investment in such co-investments are made on a pari-passu basis with the other Ares managed investment vehicles and the Company is not obligated to provide, nor has it provided, any financial support to the other Ares managed investment vehicles. As such, the Company’s risk is limited to the carrying value of its investment and the Company recognizes only the carrying value of its investment in its consolidated balance sheets. As of December 31, 2019 and 2018, the total outstanding principal balance for co-investments held by the Company was $40.9 million and $34.0 million, respectively.

Loan Purchases From Affiliate

An affiliate of the Company’s Manager maintains a $200 million real estate debt warehouse investment vehicle (the “Ares Warehouse Vehicle”) that holds Ares Management originated commercial real estate loans, which are made available to purchase by other investment vehicles, including the Company and other Ares Management managed investment vehicles. From time to time, the Company may purchase loans from the Ares Warehouse Vehicle. The Company’s Manager will approve the purchase of such loans only on terms, including the consideration to be paid, that are determined by the Company’s Manager in good faith to be appropriate for the Company once the Company has sufficient liquidity. The Company is not obligated to purchase any loans originated by the Ares Warehouse Vehicle. Loans purchased by the Company from the Ares Warehouse Vehicle are purchased at fair value as determined by an independent third-party valuation expert and are subject to approval by a majority of the Company’s independent directors.

In May 2019, the Company purchased a senior mortgage loan from the Ares Warehouse Vehicle with a commitment amount of $40.5 million on an industrial property located in North Carolina. At the May 2019 purchase date, the senior mortgage loan had a total outstanding principal balance of $34.9 million, which is included within loans held for investment in the Company’s consolidated balance sheets.
v3.19.3.a.u2
DIVIDENDS AND DISTRIBUTIONS
12 Months Ended
Dec. 31, 2019
DIVIDENDS AND DISTRIBUTIONS  
DIVIDENDS AND DISTRIBUTIONS
 DIVIDENDS AND DISTRIBUTIONS

The following table summarizes the Company’s dividends declared during the years ended December 31, 2019, 2018 and 2017 ($ in thousands, except per share data):

Date Declared
 
Record Date
 
Payment Date
 
Per Share Amount
 
Total Amount
November 8, 2019
 
December 30, 2019
 
January 15, 2020
 
$
0.33

 
$
9,546

July 26, 2019
 
September 30, 2019
 
October 15, 2019
 
0.33

 
9,526

May 1, 2019
 
June 28, 2019
 
July 16, 2019
 
0.33

 
9,527

February 21, 2019
 
March 29, 2019
 
April 16, 2019
 
0.33

 
9,520

Total cash dividends declared for the year ended December 31, 2019
 
 
 
 
 
$
1.32

 
$
38,119

October 30, 2018
 
December 28, 2018
 
January 15, 2019
 
$
0.31

 
$
8,914

July 26, 2018
 
September 28, 2018
 
October 16, 2018
 
0.29

 
8,323

May 1, 2018
 
June 29, 2018
 
July 17, 2018
 
0.28

 
8,036

March 1, 2018
 
March 29, 2018
 
April 17, 2018
 
0.28

 
8,008

Total cash dividends declared for the year ended December 31, 2018
 
 
 
 
 
$
1.16

 
$
33,281

November 1, 2017
 
December 29, 2017
 
January 16, 2018
 
$
0.27

 
$
7,722

August 3, 2017
 
September 29, 2017
 
October 16, 2017
 
0.27

 
7,717

May 2, 2017
 
June 30, 2017
 
July 17, 2017
 
0.27

 
7,718

March 7, 2017
 
March 31, 2017
 
April 17, 2017
 
0.27

 
7,690

Total cash dividends declared for the year ended December 31, 2017
 
 
 
 
 
$
1.08

 
$
30,847

v3.19.3.a.u2
VARIABLE INTEREST ENTITIES
12 Months Ended
Dec. 31, 2019
VARIABLE INTEREST ENTITIES  
VARIABLE INTEREST ENTITIES
 VARIABLE INTEREST ENTITIES

Consolidated VIEs

As discussed in Note 2, the Company evaluates all of its investments and other interests in entities for consolidation, including its investment in the CLO Securitization (as defined below), which is considered to be a variable interest in a VIE.

CLO Securitization

On January 11, 2019, ACRE Commercial Mortgage 2017-FL3 Ltd. (the “Issuer”) and ACRE Commercial Mortgage 2017-FL3 LLC (the “Co-Issuer”), both wholly-owned indirect subsidiaries of the Company, entered into an Amended and Restated Indenture (the “Amended Indenture”) with Wells Fargo Bank, National Association, as advancing agent and note administrator, and Wilmington Trust, National Association, as trustee, which governs the approximately $504.1 million principal balance of secured floating rate notes (the “Notes”) issued by the Issuer and $52.9 million of preferred equity in the Issuer (the “CLO Securitization”). The Amended Indenture amends and restates, and replaces in its entirety, the indenture for the CLO securitization issued in March 2017, which governed the issuance of approximately $308.8 million principal balance of secured floating rate notes and $32.4 million of preferred equity in the Issuer.

As of December 31, 2019, the Notes were collateralized by interests in a pool of 16 mortgage assets having a total principal balance of $515.9 million (the “Mortgage Assets”) that were originated by a wholly-owned subsidiary of the Company and approximately $41.1 million of receivables related to repayments of outstanding principal on previous mortgage assets. As of December 31, 2018, the Notes were collateralized by interests in a pool of 11 mortgage assets having a total principal balance of approximately $289.6 million that were originated by a wholly-owned subsidiary of the Company and approximately $51.6 million of receivables related to repayments of outstanding principal on previous mortgage assets. During the reinvestment period ending on March 31, 2021, the Company may direct the Issuer to acquire additional mortgage assets meeting applicable reinvestment criteria using the principal repayments from the Mortgage Assets, subject to the satisfaction of certain conditions, including receipt of a Rating Agency Confirmation and investor approval of the new mortgage assets.  

The contribution of the Mortgage Assets to the Issuer is governed by a Mortgage Asset Purchase Agreement between ACRC Lender LLC (the “Seller”), a wholly-owned subsidiary of the Company, and the Issuer, and acknowledged by the Company solely for purposes of confirming its status as a REIT, in which the Seller made certain customary representations, warranties and covenants.

In connection with the securitization, the Issuer and Co-Issuer offered and issued the following classes of Notes: Class A, Class A-S, Class B, Class C and Class D Notes (collectively, the “Offered Notes”) to a third party. The Company retained (through one of its wholly-owned subsidiaries) approximately $58.5 million of the Notes and all of the $52.9 million of preferred equity in the Issuer, which totaled $111.4 million. The Company, as the holder of the subordinated Notes and all of the preferred equity in the Issuer, has the obligation to absorb losses of the CLO, since the Company has a first loss position in the capital structure of the CLO.

After January 16, 2023, the Issuer may redeem the Offered Notes subject to paying a make whole prepayment fee of 1.0% of the then outstanding balance of the Offered Notes. In addition, once the Class A Notes, Class A-S Notes, Class B Notes and Class C Notes have been repaid in full, the Issuer has the right to redeem the Class D Notes, subject to paying a make whole prepayment fee of 1.0% on the Class D Notes.
 
As the directing holder of the CLO Securitization, the Company has the ability to direct activities that could significantly impact the CLO Securitization’s economic performance. ACRES is designated as special servicer of the CLO Securitization and has the power to direct activities during the loan workout process on defaulted and delinquent loans, which is the activity that most significantly impacts the CLO Securitization’s economic performance. ACRES did not waive the special servicing fee, and the Company pays its overhead costs. If an unrelated third party had the right to unilaterally remove the special servicer, then the Company would not have the power to direct activities that most significantly impact the CLO Securitization’s economic performance. In addition, there were no substantive kick-out rights of any unrelated third party to remove the special servicer without cause. The Company’s subsidiaries, as directing holders, have the ability to remove the special servicer without cause. Based on these factors, the Company is determined to be the primary beneficiary of the CLO Securitization; thus, the CLO Securitization is consolidated into the Company’s consolidated financial statements.

The CLO Securitization is consolidated in accordance with FASB ASC Topic 810 and is structured as a pass through entity that receives principal and interest on the underlying collateral and distributes those payments to the note holders, as applicable. The assets and other instruments held by the CLO Securitization are restricted and can only be used to fulfill the obligations of the CLO Securitization. Additionally, the obligations of the CLO Securitization do not have any recourse to the general credit of any other consolidated entities, nor to the Company as the primary beneficiary.

The inclusion of the assets and liabilities of the CLO Securitization of which the Company is deemed the primary beneficiary has no economic effect on the Company. The Company’s exposure to the obligations of the CLO Securitization is generally limited to its investment in the entity. The Company is not obligated to provide, nor has it provided, any financial support for the consolidated structure. As such, the risk associated with the Company’s involvement in the CLO Securitization is limited to the carrying value of its investment in the entity. As of December 31, 2019, the Company’s maximum risk of loss was $111.4 million, which represents the carrying value of its investment in the CLO Securitization.
v3.19.3.a.u2
QUARTERLY FINANCIAL DATA (UNAUDITED)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
QUARTERLY FINANCIAL DATA (UNAUDITED)
QUARTERLY FINANCIAL DATA (UNAUDITED)

The following table summarizes the Company’s quarterly financial results for each quarter for the years ended December 31, 2019 and 2018 ($ in thousands, except per share data):

 
For the three month period ended,
 
March 31
 
June 30
 
September 30
 
December 31
2019:
 
 
 
 
 
 
 
Net interest margin
$
12,246

 
$
13,318

 
$
13,145

 
$
13,492

Net income attributable to common stockholders
$
8,543

 
$
9,755

 
$
9,034

 
$
9,660

Net income per common share-Basic
$
0.30

 
$
0.34

 
$
0.32

 
$
0.34

Net income per common share-Diluted
$
0.30

 
$
0.34

 
$
0.31

 
$
0.33

2018:
 
 
 
 
 
 
 
Net interest margin
$
13,137

 
$
13,636

 
$
13,984

 
$
14,525

Net income attributable to common stockholders
$
9,318

 
$
9,303

 
$
9,957

 
$
10,018

Net income per common share-Basic and Diluted
$
0.33

 
$
0.33

 
$
0.35

 
$
0.35

v3.19.3.a.u2
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2019
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
 SUBSEQUENT EVENTS

The Company’s management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no subsequent events that occurred during such period that would require disclosure in this Form 10-K or would be required to be recognized in the consolidated financial statements as of and for the year ended December 31, 2019, except as disclosed below.

On January 16, 2020, the Company and a consolidated subsidiary of the Company entered into a $150.0 million master repurchase and securities contract agreement (the “Morgan Stanley Facility”) with Morgan Stanley Bank, N.A. (“Morgan Stanley”). Pursuant to the Morgan Stanley Facility, the Company is permitted to sell, and later repurchase, eligible commercial mortgage loans collateralized by retail, office, mixed-use, multifamily, industrial, hospitality, student housing or self-storage properties. Morgan Stanley may approve the mortgage loans that are subject to the Morgan Stanley Facility in its sole discretion. The initial maturity date of the Morgan Stanley Facility is January 16, 2023, and the facility is subject to two 12- month extensions at the Company’s option upon the satisfaction of certain conditions, including the payment of an extension fee. The pricing rate under the Morgan Stanley Facility will accrue at a per annum rate equal to one-month LIBOR plus a spread ranging from 1.75% to 2.25% determined by Morgan Stanley depending upon the mortgage loan sold to Morgan Stanley in the applicable transaction. The Morgan Stanley Facility contains margin call provisions following the occurrence of certain mortgage loan credit events. The Morgan Stanley Facility is partially guaranteed by the Company for up to a maximum liability of 25% of the then currently outstanding repurchase price for all purchased assets. The agreements governing the Morgan Stanley Facility also contain various customary representations and warranties and provisions regarding events of default, and impose certain customary covenants, including that the Company is obligated to maintain certain ratios of debt to net worth, fixed charges, liquidity and other financial covenants.

On January 22, 2020, the Company entered into an underwriting agreement (the “Underwriting Agreement”), by and among the Company, ACREM, and Wells Fargo Securities, LLC, Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC, as representatives of the several underwriters listed therein (collectively, the “Underwriters”). Pursuant to the terms of the Underwriting Agreement, the Company agreed to sell, and the Underwriters agreed to purchase, subject to the terms and conditions set forth in the Underwriting Agreement, an aggregate of 4,000,000 shares of the Company’s common stock, par value $0.01 per share. In addition, the Company granted to the Underwriters a 30-day option to purchase up to an additional 600,000 shares. The public offering closed on January 27, 2020 and generated estimated net proceeds of approximately $63.3 million, after deducting estimated transaction expenses. On January 30, 2020, the Company sold an additional 600,000 shares pursuant to the Underwriters option to purchase additional shares, generating additional estimated net proceeds of approximately $9.5 million.
On January 21, 2020, the Company purchased a $132.6 million senior mortgage loan on a portfolio of office properties located across multiple states from the Ares Warehouse Vehicle. At the purchase date, the outstanding principal balance was approximately $107.1 million. The loan has a per annum interest rate of LIBOR plus 3.65% (plus fees) and an initial term of three years.

On January 28, 2020, the Company originated and fully funded a $29.6 million senior mortgage loan on a multifamily property located in Texas. The loan has a per annum interest rate of LIBOR plus 3.25% (plus fees) and an initial term of three years.

On January 30, 2020, the Company originated a $56.5 million senior mortgage loan on an industrial property located in New York. At closing, the outstanding principal balance was approximately $42.5 million. The loan has a per annum interest rate of LIBOR plus 5.00% (plus fees) and an initial term of one year.

On February 10, 2020, the Company originated a $19.0 million senior mortgage loan on a multifamily property located in Washington. At closing, the outstanding principal balance was approximately $18.6 million. The loan has a per annum interest rate of LIBOR plus 3.00% (plus fees) and an initial term of three years.

On February 20, 2020, the Company declared a cash dividend of $0.33 per common share for the first quarter of 2020. The first quarter 2020 dividend is payable on April 15, 2020 to common stockholders of record as of March 31, 2020.
v3.19.3.a.u2
SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated.
Variable Interest Entities
Variable Interest Entities

The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE.
 
To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE.

To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company.
 
For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements.
 
The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change. See Note 13 included in these consolidated financial statements for further discussion of the Company’s VIEs.
Cash and Cash Equivalents
Cash, Cash Equivalents and Restricted Cash

Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short‑term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and statements of cash flows.
Restricted Cash
Restricted cash includes deposits required under certain Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements).

Concentration of Credit Risk
Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and restricted cash, loans held for investment and interest receivable. The Company places its cash and cash equivalents with financial institutions and, at times, cash held may exceed the Federal Deposit Insurance Corporation insured limit. The Company has exposure to credit risk on its loans held for investment. The Company and the Company’s Manager seek to manage credit risk by performing due diligence prior to origination or acquisition and through the use of non‑recourse financing, when and where available and appropriate.
Loans Held for Investment
Loans Held for Investment

The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired. Impairment occurs when it is deemed probable that the Company will not be able to collect all amounts due according to the contractual terms of the loan. If a loan is considered to be impaired, the Company will record an allowance to reduce the carrying value of the loan to the present value of expected future cash flows discounted at the loan’s contractual effective rate.

Each loan classified as held for investment is evaluated for impairment on a quarterly basis. Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such impairment analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors.

In addition, the Company evaluates the entire portfolio to determine whether the portfolio has any impairment that requires a valuation allowance on the remainder of the loan portfolio. For the years ended December 31, 2019, 2018 and 2017, the Company did not recognize any impairment charges with respect to its loans held for investment.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.
 
Preferred equity investments, which are subordinate to any loans but senior to common equity, are accounted for as loans held for investment and are carried at cost, net of unamortized loan fees and origination costs, unless the loans are deemed impaired, and are included within loans held for investment in the Company’s consolidated balance sheets. The Company accretes or amortizes any discounts or premiums over the life of the related loan held for investment utilizing the effective interest method.
Debt Issuance Costs
Debt Issuance Costs

Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on (i) Secured Funding Agreements (each individually defined in Note 5 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable and the Secured Term Loan (both defined in Note 5 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability, in the Company’s consolidated balance sheets. Amortization of debt issuance costs for the note payable on the hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable) is included within expenses from real estate owned in the Company’s consolidated statements of operations.

The original issue discount (“OID”) on amounts drawn under the Company’s Secured Term Loan represents a discount to the face amount of the drawn debt obligations. The OID is amortized over the term of the Secured Term Loan using the effective interest method and is included within interest expense in the Company’s consolidated statements of operations while the unamortized balance is included as a reduction to the carrying amount of the Secured Term Loan in the Company’s consolidated balance sheets.
Revenue Recognition
Revenue Recognition

Interest income from loans held for investment is accrued based on the outstanding principal amount and the contractual terms of each loan. For loans held for investment, origination fees, contractual exit fees and direct loan origination costs are also recognized in interest income from loans held for investment over the initial loan term as a yield adjustment using the effective interest method.

Revenue from real estate owned represents revenue associated with the operations of a hotel property classified as real estate owned. Revenue from the operation of the hotel property is recognized when guestrooms are occupied, services have been rendered or fees have been earned. Revenues are recorded net of any discounts and sales and other taxes collected from customers. Revenues consist of room sales, food and beverage sales and other hotel revenues.
Net Interest Margin and Interest Expense
Net Interest Margin and Interest Expense

Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans held for investment as compared to its use of debt leverage. The Company includes interest income from its loans held for investment and interest expense related to its Secured Funding Agreements, Notes Payable, securitizations debt and the Secured Term Loan (individually defined in Note 5 included in these consolidated financial statements) in net interest margin.
Income Taxes
Income Taxes

The Company has elected and qualified for taxation as a REIT commencing with its taxable year ended December 31, 2012. As a result of the Company’s REIT qualification and its distribution policy, the Company does not generally pay United States federal corporate level income taxes. Many of the REIT requirements, however, are highly technical and complex. To continue to qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement that the Company distributes annually to its stockholders at least 90% of the Company’s REIT taxable income prior to the deduction for dividends paid. To the extent that the Company distributes less than 100% of its REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), the Company will pay tax at regular corporate rates on that undistributed portion. Furthermore, if the Company distributes less than the sum of 1) 85% of its ordinary income for the calendar year, 2) 95% of its capital gain net income for the calendar year, and 3) any undistributed shortfall from its prior calendar year (the “Required Distribution”) to its stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then it is required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if the Company elects to retain any of its net capital gain for any tax year, it must notify its stockholders and pay tax at regular corporate rates on the retained net capital gain. The stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If it is determined that the Company’s estimated current year taxable income will be in excess of estimated dividend distributions (including capital gain dividend) for the current year from such income, the Company accrues excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations. Excise tax expense is included in the line item income tax expense, including excise tax in the consolidated statements of operations included in this annual report on Form 10-K.

The Company formed a wholly-owned subsidiary, ACRC Lender W TRS LLC (“ACRC W TRS”), in December 2013 in order to issue and hold certain loans intended for sale. The Company also formed a wholly-owned subsidiary, ACRC 2017-FL3 TRS LLC (“FL3 TRS”), in March 2017 in order to hold a portion of the CLO Securitization (as defined below), including the portion that generates excess inclusion income. Additionally, the Company also formed a wholly-owned subsidiary, ACRC WM Tenant LLC (“ACRC WM”), in March 2019 in order to lease the hotel property classified as real estate owned, which was acquired on March 8, 2019. Entity classification elections to be taxed as a corporation and taxable REIT subsidiary (“TRS”) elections were made with respect to ACRC W TRS, FL3 TRS and ACRC WM. A TRS is an entity taxed as a corporation that has not elected to be taxed as a REIT, in which a REIT directly or indirectly holds equity, and that has made a joint election with such REIT to be treated as a TRS. A TRS generally may engage in any business, including investing in assets and engaging in activities that could not be held or conducted directly by the Company without jeopardizing its qualification as a REIT. A TRS is subject to applicable United States federal, state and local income tax on its taxable income. In addition, as a REIT, the Company also may be subject to a 100% excise tax on certain transactions between it and its TRS that are not conducted on an arm’s-length basis. For financial reporting purposes, a provision for current and deferred taxes has been established for the portion of the Company’s GAAP consolidated earnings recognized by ACRC W TRS, FL3 TRS and ACRC WM. The income tax provision is included in the line item income tax expense, including excise tax in the consolidated statements of operations included in this annual report on Form 10-K.

FASB ASC Topic 740, Income Taxes (“ASC 740”), prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has analyzed its various federal and state filing positions and believes that its income tax filing positions and deductions are well documented and supported. As of December 31, 2019 and 2018, based on the Company’s evaluation, there is no reserve for any uncertain income tax positions. ACRC W TRS, FL3 TRS and ACRC WM recognize interest and penalties, if any, related to unrecognized tax benefits within income tax expense in the consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the consolidated balance sheets.
Comprehensive Income
Comprehensive Income

For the years ended December 31, 2019, 2018 and 2017, comprehensive income equaled net income; therefore, a separate consolidated statement of comprehensive income is not included in the accompanying consolidated financial statements.
Stock-Based Compensation
Stock‑Based Compensation

The Company recognizes the cost of stock‑based compensation, which is included within general and administrative expenses in the Company’s consolidated statements of operations. The fair value of the time vested restricted stock or restricted stock units (“RSUs”) granted is recorded to expense on a straight‑line basis over the vesting period for the award, with an offsetting increase in stockholders’ equity. For grants to directors and officers and employees of the Manager, the fair value is determined based upon the market price of the stock on the grant date.
Earnings per Share
Earnings per Share

The Company calculates basic earnings (loss) per share by dividing net income (loss) allocable to common stockholders for the period by the weighted average shares of common stock outstanding for that period after consideration of the earnings (loss) allocated to the Company’s restricted stock, which are participating securities as defined in GAAP. Diluted earnings (loss) per share takes into effect any dilutive instruments, such as restricted stock, RSUs and convertible debt, except when doing so would be anti‑dilutive.
Use of Estimates in the Preparation of Financial Statements
Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
    
In June 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard replaced the incurred loss impairment methodology pursuant to GAAP with a methodology that reflects current expected credit losses (“CECL”) on full commitment balances and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU No. 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. ASU No. 2016-13 is to be adopted through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Subsequent increases and decreases to estimated expected credit losses will flow through the Company’s consolidated statements of operations. The CECL reserve required under ASU No. 2016-13 is a valuation account that is deducted from the carrying value of loans held for investment on the Company's consolidated balance sheets. Future funding commitments on the Company's loans are also subject to a CECL reserve. The CECL reserve related to future loan fundings is recorded as a component of other liabilities in the Company's consolidated balance sheets and changes in this component of the CECL reserve will flow through the Company’s consolidated statements of operations, similar to the accounting for the CECL reserve on funded amounts.
 
The Company plans to estimate its CECL reserve primarily using a probability-weighted model that considers the likelihood of default and expected loss given default for each such individual loan. Estimating a CECL reserve requires significant judgment, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) capital senior to us when we are the subordinate lender, and (iv) our current and future view of the macroeconomic environment. Upon adoption of ASU No. 2016-13 on January 1, 2020, the Company expects that, based on current expectations of future economic conditions, its allowance for credit losses on loans held for investment, including future loan funding commitments, will be between $4.8 million and $6.7 million or 0.25% and 0.35% of the Company's total loan commitment balance of $1.9 billion as of December 31, 2019. The Company currently does not have any provision for loan losses recorded in its consolidated financial statements.
v3.19.3.a.u2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Schedule of cash and cash equivalents and restricted cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows ($ in thousands):
 
For the years ended December 31,
 
2019
 
2018
 
2017
Cash and cash equivalents
$
5,256

 
$
11,089

 
$
28,343

Restricted cash
379

 
379

 
379

Total cash, cash equivalents and restricted cash shown in the Company's consolidated statements of cash flows
$
5,635

 
$
11,468

 
$
28,722

Schedule of interest expense
For the years ended December 31, 2019, 2018 and 2017, interest expense is comprised of the following ($ in thousands):
 
For the years ended December 31,
 
2019
 
2018
 
2017
Secured funding agreements
$
32,859

 
$
43,039

 
$
29,272

Notes payable (1)
867

 

 

Securitizations debt
19,950

 
11,434

 
8,330

Secured term loan
8,907

 
8,529

 
13,591

Interest expense
$
62,583

 
$
63,002

 
$
51,193

___________________________________________________________________________

(1)
Excludes interest expense on the $28.3 million note payable, which is secured by a hotel property that is recognized as real estate owned in the Company’s consolidated balance sheets (see Note 5 included in these consolidated financial statements for additional information on the note payable). Interest expense on the $28.3 million note payable is included within expenses from real estate owned in the Company’s consolidated statements of operations.
v3.19.3.a.u2
LOANS HELD FOR INVESTMENT (Tables)
12 Months Ended
Dec. 31, 2019
Receivables [Abstract]  
Schedule of loans held for investments
The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of December 31, 2019 and 2018 ($ in thousands):

 
As of December 31, 2019
 
Carrying Amount (1)
 
Outstanding Principal (1)
 
Weighted Average Unleveraged Effective Yield (2)
 
Weighted Average Remaining Life (Years)
Senior mortgage loans
$
1,622,666

 
$
1,632,164

 
6.5
%
 
1.5
Subordinated debt and preferred equity investments
59,832

 
60,730

 
15.1
%
 
2.6
Total loans held for investment portfolio
$
1,682,498

 
$
1,692,894

 
6.8
%
 
1.6

 
As of December 31, 2018
 
Carrying Amount (1)
 
Outstanding Principal (1)
 
Weighted Average Unleveraged Effective Yield (2)
 
Weighted Average Remaining Life (Years)
Senior mortgage loans
$
1,489,708

 
$
1,498,530

 
7.0
%
 
1.7
Subordinated debt and preferred equity investments
35,165

 
36,213

 
14.9
%
 
4.3
Total loans held for investment portfolio
$
1,524,873

 
$
1,534,743

 
7.1
%
 
1.8
_______________________________________________________________________________

(1)
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
(2)
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of December 31, 2019 and 2018 as weighted by the outstanding principal balance of each loan.

Schedule of current investment portfolio and Outstanding Principal
A more detailed listing of the Company’s loans held for investment portfolio based on information available as of December 31, 2019 is as follows ($ in millions, except percentages):

Loan Type
 
Location
 
Outstanding Principal (1)
 
Carrying Amount (1)
 
Interest Rate
 
Unleveraged Effective Yield (2)
 
Maturity Date (3)
 
Payment Terms (4)
 
Senior Mortgage Loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mixed-use

FL

$100.6

$99.9

L+4.25%

7.8%

Feb 2021

I/O

Multifamily

FL

89.7

89.6

L+4.75%

6.8%

Feb 2020
(5)
I/O

Multifamily

TX

75.0

74.7

L+2.85%

5.0%

Oct 2022

I/O

Office

IL

69.2

69.0

L+3.75%

6.1%

Dec 2020

I/O

Hotel

OR/WA

68.1

67.7

L+3.45%

5.9%

May 2021

I/O

Hotel

Diversified

58.9

58.6

L+3.60%

6.2%

Sep 2021

I/O

Office

IL

57.0

56.8

L+3.95%

6.3%

Jun 2021

I/O

Industrial

FL

52.5

52.0

L+6.10%

8.8%

Oct 2022

I/O

Office

NC

49.6

49.0

L+4.25%

8.6%

Mar 2021

I/O

Mixed-use

CA

49.0

48.8

L+4.00%

6.3%

Apr 2021

I/O

Multifamily

FL

45.4

45.3

L+4.75%

6.8%

Feb 2020
(5)
I/O

Multifamily

TX

42.7

42.6

L+3.30%

5.4%

Dec 2020

I/O

Multifamily

FL

42.4

42.1

L+2.60%

5.5%

Jan 2022

I/O

Student Housing

CA

41.7

41.7

L+3.95%

6.3%

Jul 2020

I/O

Student Housing

TX

41.0

40.8

L+4.75%

7.1%

Jan 2021

I/O

Hotel

CA

40.0

39.9

L+4.12%

6.2%

Jan 2021

I/O

Multifamily

IL

39.2

39.0

L+3.50%

6.5%

Nov 2020

I/O

Office

GA

36.9

36.3

L+3.05%

5.8%

Dec 2022

I/O

Multifamily

KS

35.8

35.5

L+3.25%

5.5%

Nov 2022

I/O

Hotel

MI

35.2

35.2

L+4.40%

6.2%

Jul 2020
(6)
I/O

Industrial

NC

34.8

34.6

L+4.05%

6.1%

Mar 2024

I/O

Mixed-use

TX

33.8

33.4

L+3.75%

6.7%

Sep 2022

I/O

Hotel

IL

32.9

32.7

L+4.40%

6.8%

May 2021

I/O

Hotel

MN

31.5

31.3

L+3.55%

6.0%

Aug 2021

I/O

Office

CA

30.9

30.6

L+3.35%

6.0%

Nov 2022

I/O

Multifamily

NY

30.2

30.1

L+3.20%

5.3%

Dec 2020

I/O

Student Housing

NC

30.0

29.8

L+3.15%

5.9%

Feb 2022

I/O

Multifamily

PA

29.3

29.2

L+3.00%

5.9%

Dec 2021

I/O

Multifamily

TX

27.5

27.4

L+3.20%

5.5%

Oct 2020

I/O

Office

IL

27.5

27.2

L+3.80%

6.2%

Jan 2023

I/O

Multifamily

CA

26.8

26.7

L+3.85%

6.1%

Jul 2020

I/O

Student Housing

AL

24.1

24.1

L+4.45%

6.8%

Feb 2020

I/O

Student Housing

TX

24.0

23.9

L+4.10%

6.4%

Jan 2021

I/O

Student Housing

FL

22.0

21.8

L+3.25%

5.9%

Aug 2022

I/O

Industrial

CA

21.0

20.8

L+4.50%

7.4%

Dec 2021

I/O

Self Storage

FL

19.5

19.4

L+3.50%

6.0%

Mar 2022

I/O

Multifamily

FL

19.2

19.1

L+4.00%

6.1%

Nov 2020

I/O

Office

FL

18.4

18.4

L+4.30%

6.6%

Apr 2020

I/O

Office

CA

17.7

17.6

L+3.40%

6.3%

Nov 2021

I/O

Office

NC

13.2

13.0

L+3.51%

6.7%

May 2023

I/O

Office

TX

13.1

12.8

L+4.05%

7.5%

Nov 2021

I/O

Industrial

CA

12.7

12.6

L+3.75%

6.3%

Mar 2023

I/O

Residential

CA

11.6

11.5

13.00%
(7)
22.5%

Feb 2020

I/O

Office

NC

8.6

8.5

L+4.00%

6.7%

Nov 2022

I/O

Multifamily

SC

2.0

1.7

L+6.50%

10.1%

Sep 2022

I/O

Subordinated Debt and Preferred Equity Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Office

NJ

17.0

16.4

12.00%

12.8%

Jan 2026

I/O
(8)
Residential Condominium

NY

14.9

14.8

L+14.00%
(9)
19.1%

May 2021
(9)
I/O

Mixed-use

IL

14.5

14.3

L+12.25%

14.9%

Nov 2021

I/O

Residential Condominium

HI

11.5

11.5

14.00%

14.5%

Mar 2020
(10)
I/O

Office

CA

2.8

2.8

L+8.25%

10.2%

Nov 2021

I/O

Total/Weighted Average
 
 
 
$1,692.9
 
$1,682.5
 
 
 
6.8%
 
 
 
 
 
_______________________________________________________________________________

(1)
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 11 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected.
(2)
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of December 31, 2019 or the LIBOR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of December 31, 2019 as weighted by the outstanding principal balance of each loan.
(3)
Certain loans are subject to contractual extension options that generally vary between one and two 12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.
(4)
I/O = interest only, P/I = principal and interest.
(5)
In September 2019, the Company and the borrower entered into an extension agreement, which extended the maturity date on the senior Florida loan to February 2020.
(6)
In May 2019, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Michigan loan to July 2020.
(7)
In November 2019, the Company and the borrowers entered into a modification agreement to, among other things, waive certain performance hurdles associated with the borrowers’ business plan and increase the interest rate from a per annum rate of 12.00% to 13.00% on the senior California loan.
(8)
In February 2021, amortization will begin on the subordinated New Jersey loan, which had an outstanding principal balance of $17.0 million as of December 31, 2019. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.
(9)
In September 2019, the Company and the borrower entered into a modification agreement to, among other things, loan an additional $2.1 million to the borrower on the subordinated New York loan, for which such amount accrues interest at a per annum rate of 20.00% and has an initial maturity date of April 2020. The remaining outstanding principal balance of the subordinated New York loan continues to accrue interest at L + 14.00% and has an initial maturity date of May 2021.
(10)
In September 2019, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the subordinated Hawaii loan to March 2020.

Schedule of activity in loan portfolio
For the years ended December 31, 2019 and 2018, the activity in the Company’s loan portfolio was as follows ($ in thousands):

Balance at December 31, 2017
$
1,726,283

Initial funding
510,529

Origination fees and discounts, net of costs
(5,816
)
Additional funding
33,693

Amortizing payments
(645
)
Loan payoffs
(746,120
)
Origination fee accretion
6,949

Balance at December 31, 2018
$
1,524,873

Initial funding
493,913

Origination fees and discounts, net of costs
(7,539
)
Additional funding
185,281

Amortizing payments

Loan payoffs
(482,407
)
Loan converted to real estate owned (see Note 4)
(38,636
)
Origination fee accretion
7,013

Balance at December 31, 2019
$
1,682,498


v3.19.3.a.u2
REAL ESTATE OWNED (Tables)
12 Months Ended
Dec. 31, 2019
Real Estate Owned [Abstract]  
Schedule of Real Estate Properties
The following table summarizes the Company’s real estate owned as of December 31, 2019 ($ in thousands):

 
December 31, 2019
Land
$
10,200

Buildings and improvements
24,281

Furniture, fixtures and equipment
4,087

 
38,568

Less: Accumulated depreciation
(667
)
Real estate owned, net
$
37,901

v3.19.3.a.u2
DEBT (Tables)
12 Months Ended
Dec. 31, 2019
Debt Disclosure [Abstract]  
Schedule of outstanding balances and total commitments under the Funding Agreements
As of December 31, 2019 and 2018, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands):

 
As of December 31,
 
2019
 
2018
 
 
Outstanding Balance
 
Total
Commitment
 
Outstanding Balance
 
Total
Commitment
 
Wells Fargo Facility
$
360,354

 
$
500,000

 
$
274,071

 
$
500,000

 
Citibank Facility
126,603

 
325,000

 
184,003

 
325,000

 
BAML Facility
36,280

 
36,280

(1)
36,280

 
125,000

 
CNB Facility
30,500

 
50,000

(2)

 
50,000

 
MetLife Facility
131,807

 
180,000

 
135,145

 
180,000

 
U.S. Bank Facility
43,045

 
185,989

 
148,475

 
185,989

 
Notes Payable
56,155

 
84,155

 

 

 
Secured Term Loan
110,000

 
110,000

 
110,000

 
110,000

 
   Total
$
894,744

 
$
1,471,424

 
$
887,974

 
$
1,475,989

 
______________________________________________________________________________

(1)
In May 2019, the Company’s borrowing period for new individual loans under the BAML Facility (as defined below) expired and its term was not extended. As such, the total commitment amount under the BAML Facility as of December 31, 2019 represents the outstanding balance under the facility at the time the borrowing period expired, which was permitted to remain outstanding until September 2019, per the original terms of the BAML Facility. In September 2019, the Company amended the BAML Facility to extend the maturity date for the outstanding balance to December 4, 2019. In addition, in December 2019, the Company amended the BAML Facility to extend the maturity date for the outstanding balance to March 3, 2020.
    
(2)
In June 2019, the Company amended the CNB Facility (as defined below) to add an accordion feature that provides for, subject to approval by City National Bank in its sole discretion, an increase in the commitment amount from $50.0 million to $75.0 million for up to a period of 120 days once per calendar year.

Schedule of principal maturities of the Company's secured funding agreements and the 2015 Convertible Notes
At December 31, 2019, approximate principal maturities of the Company’s Financing Agreements are as follows ($ in thousands):


Wells Fargo
Facility
 
Citibank
Facility
 
BAML Facility
 
CNB
Facility
 
MetLife Facility
 
U.S. Bank Facility
 
Notes Payable
 
Secured Term Loan
 
Total
2020
$
360,354

 
$

 
$
36,280

 
$
30,500

 
$
131,807

 
$
43,045

 
$

 
$
110,000

 
$
711,986

2021

 
126,603

 

 

 

 

 

 

 
126,603

2022

 

 

 

 

 

 

 

 

2023

 

 

 

 

 

 

 

 

2024

 

 

 

 

 

 
56,155

 

 
56,155

Thereafter

 

 

 

 

 

 

 

 


$
360,354

 
$
126,603

 
$
36,280

 
$
30,500

 
$
131,807

 
$
43,045

 
$
56,155

 
$
110,000

 
$
894,744

v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES (Tables)
12 Months Ended
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Schedule of loan commitments
As of December 31, 2019 and 2018, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands):
 
As of December 31,
 
2019
 
2018
Total commitments
$
1,909,084

 
$
1,677,615

Less: funded commitments
(1,692,894
)
 
(1,534,743
)
Total unfunded commitments
$
216,190

 
$
142,872

v3.19.3.a.u2
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]  
Schedule of restricted stock grants awarded
The following table details the restricted stock and RSU grants awarded as of December 31, 2019:

Grant Date
 
Vesting Start Date
 
Shares Granted
 
May 1, 2012
 
July 1, 2012
 
35,135

 
June 18, 2012
 
July 1, 2012
 
7,027

 
July 9, 2012
 
October 1, 2012
 
25,000

 
June 26, 2013
 
July 1, 2013
 
22,526

 
November 25, 2013
 
November 25, 2016
 
30,381

 
January 31, 2014
 
August 31, 2015
 
48,273

 
February 26, 2014
 
February 26, 2014
 
12,030

 
February 27, 2014
 
August 27, 2014
 
22,354

 
June 24, 2014
 
June 24, 2014
 
17,658

 
June 24, 2015
 
July 1, 2015
 
25,555

 
April 25, 2016
 
July 1, 2016
 
10,000

 
June 27, 2016
 
July 1, 2016
 
24,680

 
April 25, 2017
 
April 25, 2018
 
81,710

 
June 7, 2017
 
July 1, 2017
 
18,224

 
October 17, 2017
 
January 2, 2018
 
7,278

 
December 15, 2017
 
January 2, 2018
 
8,948

 
May 14, 2018
 
July 2, 2018
 
31,766

 
June 26, 2018
 
July 1, 2019
 
67,918

 
December 14, 2018
 
March 31, 2019
 
57,065

 
March 7, 2019
 
April 1, 2020
 
102,300

 
April 23, 2019
 
July 1, 2019
 
19,665

 
December 20, 2019
 
March 31, 2020
 
61,594

(1)
Total
 
 
 
737,087

 

______________________________________________________________________________

(1)    Represents an RSU grant.
Schedule of restricted stock award activity
Schedule of Non-Vested Share and Share Equivalents

 
 Restricted Stock Grants—Directors
 
Restricted Stock Grants—Officers and Employees of the Manager
 
RSUs—Officers and Employees of the Manager
 
Total
Balance at December 31, 2018
22,554

 
179,456

 

 
202,010

Granted
19,665

 
102,300

 
61,594

 
183,559

Vested
(25,853
)
 
(62,303
)
 

 
(88,156
)
Forfeited
(4,034
)
 
(7,986
)
 

 
(12,020
)
Balance at December 31, 2019
12,332

 
211,467

 
61,594

 
285,393

Future anticipated vesting schedule of restricted stock awards
Future Anticipated Vesting Schedule

 
Restricted Stock Grants—Directors
 
Restricted Stock Grants—Officers and Employees of the Manager
 
RSUs—Officers and Employees of the Manager
 
Total
2020
11,498

 
96,752

 
9,944

 
118,194

2021
834

 
69,510

 
17,222

 
87,566

2022

 
45,205

 
17,219

 
62,424

2023

 

 
17,209

 
17,209

2024

 

 

 

Total
12,332

 
211,467

 
61,594

 
285,393


Summary of activity in the Company's vested and nonvested shares of restricted stock
The following table summarizes the restricted stock and RSU compensation expense included within general and administrative expenses in the Company’s consolidated statements of operations, the total fair value of shares vested and the weighted average grant date fair value of the restricted stock and RSUs granted to the Company’s directors and officers and employees of the Manager for the years ended December 31, 2019, 2018 and 2017 ($ in thousands):
 
For the years ended December 31,
 
2019
 
2018
 
2017
 
Restricted Stock and RSU Grants
 
Restricted Stock Grants
 
Restricted Stock Grants
 
Directors
 
Officers and Employees of the Manager
 
Total
 
Directors
 
Officers and Employees of the Manager
 
Total
 
Directors
 
Officers and Employees of the Manager
 
Total
Compensation expense
$
343

 
$
1,537

 
$
1,880

 
$
427

 
$
675

 
$
1,102

 
$
317

 
$
264

 
$
581

Total fair value of shares vested (1)
373

 
939

 
1,312

 
405

 
449

 
854

 
347

 

 
347

Weighted average grant date fair value
302

 
2,527

 
2,829

 
427

 
1,759

 
2,186

 
338

 
1,254

 
1,592

______________________________________________________________________________

(1)    Based on the closing price of the Company’s common stock on the NYSE on each vesting date.

v3.19.3.a.u2
EARNINGS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
Schedule of computations of basic and diluted earnings per share
The following information sets forth the computations of basic and diluted earnings per common share for the years ended December 31, 2019, 2018 and 2017 ($ in thousands, except share and per share data):

 
For the years ended December 31,
 
2019
 
2018
 
2017
Net income attributable to common stockholders
$
36,991

 
$
38,596

 
$
30,407

Divided by:
 
 


 


Basic weighted average shares of common stock outstanding:
28,609,282

 
28,529,439

 
28,478,237

Weighted average non-vested restricted stock and RSUs
237,359

 
127,221

 
72,708

Diluted weighted average shares of common stock outstanding:
28,846,641

 
28,656,660

 
28,550,945

Basic earnings per common share
$
1.29

 
$
1.35

 
$
1.07

Diluted earnings per common share
$
1.28

 
$
1.35

 
$
1.07

v3.19.3.a.u2
INCOME TAX (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of components of the TRS's income tax provision
The income tax provision for the Company and the TRSs consisted of the following for the years ended December 31, 2019, 2018 and 2017 ($ in thousands):

 
For the years ended December 31,
 
2019
 
2018
 
2017
Current
$
114

 
$
84

 
$
25

Deferred
99

 

 

Excise tax
302

 
362

 
153

   Total income tax expense, including excise tax
$
515

 
$
446

 
$
178

v3.19.3.a.u2
FAIR VALUE (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of carrying value and estimated fair value of the Company's financial instruments not carried at fair value on the consolidated balance sheet
As of December 31, 2019 and 2018, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands):

 
 
 
As of December 31,
 
 
 
2019
 
2018
 
Level in Fair Value Hierarchy
 
Carrying Value
 
Fair
Value
 
Carrying Value
 
Fair
Value
Financial assets:
 
 
 
 
 
 
 
 
 
   Loans held for investment
3
 
$
1,682,498

 
$
1,692,894

 
$
1,524,873

 
$
1,534,743

Financial liabilities:
 
 
 
 
 
 
 
 
 
   Secured funding agreements
2
 
$
728,589

 
$
728,589

 
$
777,974

 
$
777,974

   Notes payable
2
 
54,708

 
56,155

 

 

   Secured term loan
2
 
109,149

 
110,000

 
108,345

 
110,000

Collateralized loan obligation securitization debt (consolidated VIE)
3
 
443,177

 
445,600

 
270,737

 
272,927

v3.19.3.a.u2
RELATED PARTY TRANSACTIONS (Tables)
12 Months Ended
Dec. 31, 2019
Related Party Transactions [Abstract]  
Summary of related-party costs incurred by the Company and amounts payable to the Manager
The following table summarizes the related party costs incurred by the Company for the years ended December 31, 2019, 2018 and 2017 and amounts payable to the Company’s Manager as of December 31, 2019 and 2018 ($ in thousands):

 
Incurred
 
Payable
 
For the years ended December 31,
 
As of December 31,
 
2019
 
2018
 
2017
 
2019
 
2018
Affiliate Payments
 
 
 
 
 
 
 
 
 
Management fees
$
6,311

 
$
6,268

 
$
6,188

 
$
1,581

 
$
1,576

Incentive fees
1,052

 
1,150

 
381

 
378

 
540

General and administrative expenses
3,026

 
3,570

 
3,899

 
789

 
996

Direct costs (1)
192

 
224

 
304

 
13

 
51

Total
$
10,581

 
$
11,212

 
$
10,772

 
$
2,761

 
$
3,163

______________________________________________________________________________

(1)
For the years ended December 31, 2019, 2018 and 2017, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.

v3.19.3.a.u2
DIVIDENDS AND DISTRIBUTIONS (Tables)
12 Months Ended
Dec. 31, 2019
DIVIDENDS AND DISTRIBUTIONS  
Summary of the Company's dividends declared
The following table summarizes the Company’s dividends declared during the years ended December 31, 2019, 2018 and 2017 ($ in thousands, except per share data):

Date Declared
 
Record Date
 
Payment Date
 
Per Share Amount
 
Total Amount
November 8, 2019
 
December 30, 2019
 
January 15, 2020
 
$
0.33

 
$
9,546

July 26, 2019
 
September 30, 2019
 
October 15, 2019
 
0.33

 
9,526

May 1, 2019
 
June 28, 2019
 
July 16, 2019
 
0.33

 
9,527

February 21, 2019
 
March 29, 2019
 
April 16, 2019
 
0.33

 
9,520

Total cash dividends declared for the year ended December 31, 2019
 
 
 
 
 
$
1.32

 
$
38,119

October 30, 2018
 
December 28, 2018
 
January 15, 2019
 
$
0.31

 
$
8,914

July 26, 2018
 
September 28, 2018
 
October 16, 2018
 
0.29

 
8,323

May 1, 2018
 
June 29, 2018
 
July 17, 2018
 
0.28

 
8,036

March 1, 2018
 
March 29, 2018
 
April 17, 2018
 
0.28

 
8,008

Total cash dividends declared for the year ended December 31, 2018
 
 
 
 
 
$
1.16

 
$
33,281

November 1, 2017
 
December 29, 2017
 
January 16, 2018
 
$
0.27

 
$
7,722

August 3, 2017
 
September 29, 2017
 
October 16, 2017
 
0.27

 
7,717

May 2, 2017
 
June 30, 2017
 
July 17, 2017
 
0.27

 
7,718

March 7, 2017
 
March 31, 2017
 
April 17, 2017
 
0.27

 
7,690

Total cash dividends declared for the year ended December 31, 2017
 
 
 
 
 
$
1.08

 
$
30,847

v3.19.3.a.u2
QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Summary of the entity's quarterly financial results
The following table summarizes the Company’s quarterly financial results for each quarter for the years ended December 31, 2019 and 2018 ($ in thousands, except per share data):

 
For the three month period ended,
 
March 31
 
June 30
 
September 30
 
December 31
2019:
 
 
 
 
 
 
 
Net interest margin
$
12,246

 
$
13,318

 
$
13,145

 
$
13,492

Net income attributable to common stockholders
$
8,543

 
$
9,755

 
$
9,034

 
$
9,660

Net income per common share-Basic
$
0.30

 
$
0.34

 
$
0.32

 
$
0.34

Net income per common share-Diluted
$
0.30

 
$
0.34

 
$
0.31

 
$
0.33

2018:
 
 
 
 
 
 
 
Net interest margin
$
13,137

 
$
13,636

 
$
13,984

 
$
14,525

Net income attributable to common stockholders
$
9,318

 
$
9,303

 
$
9,957

 
$
10,018

Net income per common share-Basic and Diluted
$
0.33

 
$
0.33

 
$
0.35

 
$
0.35



v3.19.3.a.u2
SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Jan. 01, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Minimum period of past due loans to be placed on non accrual 30 days      
Impairments of loan held for investment $ 0 $ 0 $ 0  
Furniture, fixtures and equipment        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Useful life 15 years      
Minimum | Accounting Standards Update 2016-13 | Subsequent event        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Allowance for credit loss       $ 4,800,000
Allowance for credit loss, percent of total commitment balance       0.25%
Maximum | Accounting Standards Update 2016-13 | Subsequent event        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Allowance for credit loss       $ 6,700,000
Allowance for credit loss, percent of total commitment balance       0.35%
Maximum | Furniture, fixtures and equipment        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Useful life 40 years      
v3.19.3.a.u2
SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Accounting Policies [Abstract]        
Cash and cash equivalents $ 5,256 $ 11,089 $ 28,343  
Restricted cash 379 379 379  
Total cash, cash equivalents and restricted cash shown in the Company's consolidated statements of cash flows $ 5,635 $ 11,468 $ 28,722 $ 47,645
v3.19.3.a.u2
SIGNIFICANT ACCOUNTING POLICIES - Schedule of Interest Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Interest expense $ 62,583 $ 63,002 $ 51,193
Secured funding agreements      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Interest expense 32,859 43,039 29,272
Notes Payable      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Interest expense 867 0 0
Interest Expense from Real Estate Owned 28,300    
Securitizations debt      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Interest expense 19,950 11,434 8,330
Secured term loan      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Interest expense $ 8,907 $ 8,529 $ 13,591
v3.19.3.a.u2
SIGNIFICANT ACCOUNTING POLICIES - Income Taxes (Details)
12 Months Ended
Dec. 31, 2019
ACRC Lender UTRS LLC  
Income Tax [Line Items]  
Excise tax rate 100.00%
Percentage of ownership in subsidiaries 100.00%
ACRC Lender WTRS LLC | ACRE Capital  
Income Tax [Line Items]  
Excise tax rate 100.00%
Percentage of ownership in subsidiaries 100.00%
v3.19.3.a.u2
LOANS HELD FOR INVESTMENT - Narrative (Details)
12 Months Ended
Dec. 31, 2019
USD ($)
Loan
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Number of loans originated or co-originated | Loan 50    
Number of loans repaid or sold | Loan 88    
Total Commitment $ 1,900,000,000    
Loans held for investment 1,682,498,000 $ 1,524,873,000 $ 1,726,283,000
Amount funded 679,200,000    
Amount of repayments $ 482,400,000    
Percentage of loans held for investment having LIBOR floors 93.00%    
Weighted average floor (as a percent) 1.76%    
Impairment charges recognized $ 0 $ 0 $ 0
Senior Mortgage Loans      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Number of loans with outstanding principal | Loan 1    
Loan converted to real estate owned $ 38,600,000    
v3.19.3.a.u2
LOANS HELD FOR INVESTMENT - Loans Held for Investment (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Carrying Amount $ 1,682,498,000 $ 1,524,873,000
Outstanding principal $ 1,692,894,000 $ 1,534,743,000
Unleveraged Effective Yield 6.80% 7.10%
Weighted Average Remaining Life 1 year 7 months 6 days 1 year 9 months 18 days
Mortgage loans on real estate $ 0  
Senior mortgage loans    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Carrying Amount 1,622,666,000 $ 1,489,708,000
Outstanding principal $ 1,632,164,000 $ 1,498,530,000
Unleveraged Effective Yield 6.50% 7.00%
Weighted Average Remaining Life 1 year 6 months 1 year 8 months 12 days
Subordinated debt and preferred equity investments    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Carrying Amount $ 59,832,000 $ 35,165,000
Outstanding principal $ 60,730,000 $ 36,213,000
Unleveraged Effective Yield 15.10% 14.90%
Weighted Average Remaining Life 2 years 7 months 6 days 4 years 3 months 18 days
v3.19.3.a.u2
LOANS HELD FOR INVESTMENT - Investment Portfolio (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2019
USD ($)
extension_option
Dec. 31, 2018
USD ($)
Mar. 08, 2019
USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 1,692,894 $ 1,534,743  
Carrying Amount   $ 1,682,498 $ 1,524,873  
Unleveraged Effective Yield   6.80% 7.10%  
Minimum        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Number of extension pptions | extension_option   1    
Maximum        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Number of extension pptions | extension_option   2    
Extension period of maturity date   12 months    
Residential        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Carrying Amount   $ 40,900 $ 34,000  
Senior Mortgage Loans | FLORIDA | LIBOR Plus 4.25% Due February 2021 | Mixed-use        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   100,600    
Carrying Amount   $ 99,900    
Unleveraged Effective Yield   7.80%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 4.25% Due February 2021 | LIBOR | Mixed-use        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.25%    
Senior Mortgage Loans | FLORIDA | LIBOR 4.75% Due February 2020 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 89,700    
Carrying Amount   $ 89,600    
Unleveraged Effective Yield   6.80%    
Senior Mortgage Loans | FLORIDA | LIBOR 4.75% Due February 2020 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.75%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 6.10% Due October 2022 | Industrial        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 52,500    
Carrying Amount   $ 52,000    
Unleveraged Effective Yield   8.80%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 6.10% Due October 2022 | LIBOR | Industrial        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   6.10%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 4.75%, Due February 2020, Instrument 2 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 45,400    
Carrying Amount   $ 45,300    
Unleveraged Effective Yield   6.80%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 4.75%, Due February 2020, Instrument 2 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.75%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 2.60%, Due January 2022 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 42,400    
Carrying Amount   $ 42,100    
Unleveraged Effective Yield   5.50%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 2.60%, Due January 2022 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   2.60%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 3.25%,Due August 2022 | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 22,000    
Carrying Amount   $ 21,800    
Unleveraged Effective Yield   5.90%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 3.25%,Due August 2022 | LIBOR | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.25%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 3.50%, Due March 2022 | Self Storage        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 19,500    
Carrying Amount   $ 19,400    
Unleveraged Effective Yield   6.00%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 3.50%, Due March 2022 | LIBOR | Self Storage        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.50%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 4.00%, Due November 2020 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 19,200    
Carrying Amount   $ 19,100    
Unleveraged Effective Yield   6.10%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 4.00%, Due November 2020 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.00%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 4.30%, Due April 2020 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 18,400    
Carrying Amount   $ 18,400    
Unleveraged Effective Yield   6.60%    
Senior Mortgage Loans | FLORIDA | LIBOR Plus 4.30%, Due April 2020 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.30%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 2.85% Due October 2022 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 75,000    
Carrying Amount   $ 74,700    
Unleveraged Effective Yield   5.00%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 2.85% Due October 2022 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   2.85%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 3.30%, Due December 2020 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 42,700    
Carrying Amount   $ 42,600    
Unleveraged Effective Yield   5.40%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 3.30%, Due December 2020 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.30%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 4.75%, Due Jan 2021 | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 41,000    
Carrying Amount   $ 40,800    
Unleveraged Effective Yield   7.10%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 4.75%, Due Jan 2021 | LIBOR | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.75%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 3.75%, Due September 2022 | Mixed-use        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 33,800    
Carrying Amount   $ 33,400    
Unleveraged Effective Yield   6.70%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 3.75%, Due September 2022 | LIBOR | Mixed-use        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.75%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 3.20%, Due October 2020 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 27,500    
Carrying Amount   $ 27,400    
Unleveraged Effective Yield   5.50%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 3.20%, Due October 2020 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.20%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 4.10%, Due January 2021 | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 24,000    
Carrying Amount   $ 23,900    
Unleveraged Effective Yield   6.40%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 4.10%, Due January 2021 | LIBOR | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.10%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 4. 05%, Due November 2021 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 13,100    
Carrying Amount   $ 12,800    
Unleveraged Effective Yield   7.50%    
Senior Mortgage Loans | TEXAS | LIBOR Plus 4. 05%, Due November 2021 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.05%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 3.75%, Due December 2020 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 69,200    
Carrying Amount   $ 69,000    
Unleveraged Effective Yield   6.10%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 3.75%, Due December 2020 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.75%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 3.95%, Due June 2021 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 57,000    
Carrying Amount   $ 56,800    
Unleveraged Effective Yield   6.30%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 3.95%, Due June 2021 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.95%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 3.50%, Due November 2020 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 39,200    
Carrying Amount   $ 39,000    
Unleveraged Effective Yield   6.50%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 3.50%, Due November 2020 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.50%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 4.40%, Due May 2021 | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 32,900    
Carrying Amount   $ 32,700    
Unleveraged Effective Yield   6.80%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 4.40%, Due May 2021 | LIBOR | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.40%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 3.80% Due January 2023 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 27,500    
Carrying Amount   $ 27,200    
Unleveraged Effective Yield   6.20%    
Senior Mortgage Loans | ILLINOIS | LIBOR Plus 3.80% Due January 2023 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.80%    
Senior Mortgage Loans | OREGON/WASHINGTON | LIBOR Plus 3.45%, Due May 2021 | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 68,100    
Carrying Amount   $ 67,700    
Unleveraged Effective Yield   5.90%    
Senior Mortgage Loans | OREGON/WASHINGTON | LIBOR Plus 3.45%, Due May 2021 | LIBOR | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.45%    
Senior Mortgage Loans | Diversified | LIBOR Plus 3.60%, Due September 2021 | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 58,900    
Carrying Amount   $ 58,600    
Unleveraged Effective Yield   6.20%    
Senior Mortgage Loans | Diversified | LIBOR Plus 3.60%, Due September 2021 | LIBOR | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.60%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 4.25% Due March 2021 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 49,600    
Carrying Amount   $ 49,000    
Unleveraged Effective Yield   8.60%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 4.25% Due March 2021 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.25%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 4.05%, Due March 2024 | Industrial        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 34,800    
Carrying Amount   $ 34,600    
Unleveraged Effective Yield   6.10%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 4.05%, Due March 2024 | LIBOR | Industrial        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.05%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 3.15%, Due Feb 2022 | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 30,000    
Carrying Amount   $ 29,800    
Unleveraged Effective Yield   5.90%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 3.15%, Due Feb 2022 | LIBOR | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.15%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 3 .51% Percent May 2023 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 13,200    
Carrying Amount   $ 13,000    
Unleveraged Effective Yield   6.70%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 3 .51% Percent May 2023 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.51%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 4.00%, Due November 2022 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 8,600    
Carrying Amount   $ 8,500    
Unleveraged Effective Yield   6.70%    
Senior Mortgage Loans | NORTH CAROLINA | LIBOR Plus 4.00%, Due November 2022 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.00%    
Senior Mortgage Loans | CALIFORNIA | Residential        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 11,600    
Carrying Amount   $ 11,500    
Fixed interest rate   13.00%    
Unleveraged Effective Yield   22.50%    
Senior Mortgage Loans | CALIFORNIA | Residential | Minimum        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Fixed interest rate   12.00%    
Senior Mortgage Loans | CALIFORNIA | Residential | Maximum        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Fixed interest rate   13.00%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 4.00%, Due April 2021 | Mixed-use        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 49,000    
Carrying Amount   $ 48,800    
Unleveraged Effective Yield   6.30%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 4.00%, Due April 2021 | LIBOR | Mixed-use        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.00%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.95%, Due July 2020 | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 41,700    
Carrying Amount   $ 41,700    
Unleveraged Effective Yield   6.30%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.95%, Due July 2020 | LIBOR | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.95%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 4.12%, Due January 2021 | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 40,000    
Carrying Amount   $ 39,900    
Unleveraged Effective Yield   6.20%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 4.12%, Due January 2021 | LIBOR | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.12%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.35% Due November 2022 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 30,900    
Carrying Amount   $ 30,600    
Unleveraged Effective Yield   6.00%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.35% Due November 2022 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.35%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.85%, Due July 2020 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 26,800    
Carrying Amount   $ 26,700    
Unleveraged Effective Yield   6.10%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.85%, Due July 2020 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.85%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 4.50% Due December 2021 | Industrial        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 21,000    
Carrying Amount   $ 20,800    
Unleveraged Effective Yield   7.40%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 4.50% Due December 2021 | LIBOR | Industrial        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.50%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.40%, Due November 2021 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 17,700    
Carrying Amount   $ 17,600    
Unleveraged Effective Yield   6.30%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.40%, Due November 2021 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.40%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.75%, Due March 2023 | Industrial        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 12,700    
Carrying Amount   $ 12,600    
Unleveraged Effective Yield   6.30%    
Senior Mortgage Loans | CALIFORNIA | LIBOR Plus 3.75%, Due March 2023 | LIBOR | Industrial        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.75%    
Senior Mortgage Loans | GEORGIA | LIBOR Plus 3.05% Due December 2022 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 36,900    
Carrying Amount   $ 36,300    
Unleveraged Effective Yield   5.80%    
Senior Mortgage Loans | GEORGIA | LIBOR Plus 3.05% Due December 2022 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.05%    
Senior Mortgage Loans | KANSAS | LIBOR Plus 3.25% Due November 2022 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 35,800    
Carrying Amount   $ 35,500    
Unleveraged Effective Yield   5.50%    
Senior Mortgage Loans | KANSAS | LIBOR Plus 3.25% Due November 2022 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.25%    
Senior Mortgage Loans | MICHIGAN | LIBOR Plus 4.40%, Due July 2020 | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 35,200    
Carrying Amount   $ 35,200    
Unleveraged Effective Yield   6.20%    
Senior Mortgage Loans | MICHIGAN | LIBOR Plus 4.40%, Due July 2020 | LIBOR | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.40%    
Senior Mortgage Loans | MINNESOTA | LIBOR Plus 3.55%, Due August 2021 | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 31,500    
Carrying Amount   $ 31,300    
Unleveraged Effective Yield   6.00%    
Senior Mortgage Loans | MINNESOTA | LIBOR Plus 3.55%, Due August 2021 | LIBOR | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.55%    
Senior Mortgage Loans | NEW YORK | Hotel        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal       $ 38,600
Senior Mortgage Loans | NEW YORK | LIBOR Plus 3.20%, Due December 2020 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 30,200    
Carrying Amount   $ 30,100    
Unleveraged Effective Yield   5.30%    
Senior Mortgage Loans | NEW YORK | LIBOR Plus 3.20%, Due December 2020 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.20%    
Senior Mortgage Loans | PENNSYLVANIA | LIBOR Plus 3.00%, Due December 2021 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 29,300    
Carrying Amount   $ 29,200    
Unleveraged Effective Yield   5.90%    
Senior Mortgage Loans | PENNSYLVANIA | LIBOR Plus 3.00%, Due December 2021 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   3.00%    
Senior Mortgage Loans | ALABAMA | LIBOR Plus 4.45% Due February 2020 | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 24,100    
Carrying Amount   $ 24,100    
Unleveraged Effective Yield   6.80%    
Senior Mortgage Loans | ALABAMA | LIBOR Plus 4.45% Due February 2020 | LIBOR | Student Housing        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   4.45%    
Senior Mortgage Loans | SOUTH CAROLINA | LIBOR Plus 6. 50% Due September 2022 | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 2,000    
Carrying Amount   $ 1,700    
Unleveraged Effective Yield   10.10%    
Senior Mortgage Loans | SOUTH CAROLINA | LIBOR Plus 6. 50% Due September 2022 | LIBOR | Multifamily        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   6.50%    
Subordinated debt and preferred equity investments | ILLINOIS | LIBOR Plus 12.25%, Due November 2021 | Mixed-use        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 14,500    
Carrying Amount   $ 14,300    
Unleveraged Effective Yield   14.90%    
Subordinated debt and preferred equity investments | ILLINOIS | LIBOR Plus 12.25%, Due November 2021 | LIBOR | Mixed-use        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   12.25%    
Subordinated debt and preferred equity investments | CALIFORNIA | LIBOR Plus 8.25%, Due November 2021 | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 2,800    
Carrying Amount   $ 2,800    
Unleveraged Effective Yield   10.20%    
Subordinated debt and preferred equity investments | CALIFORNIA | LIBOR Plus 8.25%, Due November 2021 | LIBOR | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   8.25%    
Subordinated debt and preferred equity investments | NEW YORK | LIBOR | Residential        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 2,100    
Fixed interest rate 20.00%      
Subordinated debt and preferred equity investments | NEW YORK | LIBOR Plus 14.00%, Due May 2021 | Residential Condominium        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   14,900    
Carrying Amount   $ 14,800    
Unleveraged Effective Yield   19.10%    
Subordinated debt and preferred equity investments | NEW YORK | LIBOR Plus 14.00%, Due May 2021 | LIBOR | Residential Condominium        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Basis spread on variable rate   14.00%    
Subordinated debt and preferred equity investments | NEW JERSEY | Office        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 17,000    
Carrying Amount   $ 16,400    
Fixed interest rate   12.00%    
Unleveraged Effective Yield   12.80%    
Subordinated debt and preferred equity investments | HAWAII | Residential Condominium        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding principal   $ 11,500    
Carrying Amount   $ 11,500    
Fixed interest rate   14.00%    
Unleveraged Effective Yield   14.50%    
v3.19.3.a.u2
LOANS HELD FOR INVESTMENT - Portfolio Activity (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Change in the activity of loan portfolio      
Balance at the beginning of the period $ 1,524,873 $ 1,726,283  
Initial funding 493,913 510,529  
Origination fees and discounts, net of costs (7,539) (5,816)  
Additional funding 185,281 33,693  
Amortizing payments 0 (645)  
Loan payoffs (482,407) (746,120)  
Loan converted to real estate owned (38,636)    
Origination fee accretion 7,013 6,949 $ 6,578
Balance at the end of the period $ 1,682,498 $ 1,524,873 $ 1,726,283
v3.19.3.a.u2
REAL ESTATE OWNED - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Mar. 08, 2019
Dec. 31, 2018
Outstanding principal $ 1,692,894,000   $ 1,534,743,000
Real estate owned, net 37,901,000   $ 0
Hotel | NEW YORK      
Real estate owned, net 37,901,000    
Repossessed hotel property 38,568,000    
Asset impairment charges recognized for real estate owned 0    
Depreciation expense $ 667,000    
Hotel | NEW YORK | Senior Mortgage Loans      
Outstanding principal   $ 38,600,000  
Debt derecognized   38,600,000  
Real estate owned, net   36,900,000  
Other repossessed hotel assets   1,700,000  
Repossessed hotel property   $ 38,600,000  
v3.19.3.a.u2
REAL ESTATE OWNED - Schedule of Real Estate Owned, net (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Real estate owned, net $ 37,901 $ 0
Hotel | NEW YORK    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Repossessed hotel property 38,568  
Less: Accumulated depreciation (667)  
Real estate owned, net 37,901  
Land | Hotel | NEW YORK    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Repossessed hotel property 10,200  
Buildings and improvements | Hotel | NEW YORK    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Repossessed hotel property 24,281  
Furniture, fixtures and equipment | Hotel | NEW YORK    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Repossessed hotel property $ 4,087  
v3.19.3.a.u2
DEBT - Schedule of outstanding balances and total commitments under Financing Agreements (Details) - USD ($)
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2018
Debt Instrument [Line Items]      
Outstanding balance $ 894,744,000   $ 887,974,000
Total Commitment 1,471,424,000   1,475,989,000
Secured term loan      
Debt Instrument [Line Items]      
Outstanding balance 110,000,000   110,000,000
Total Commitment 110,000,000   110,000,000
Wells Fargo Facility      
Debt Instrument [Line Items]      
Outstanding balance 360,354,000   274,071,000
Total Commitment 500,000,000   500,000,000
Citibank Facility      
Debt Instrument [Line Items]      
Outstanding balance 126,603,000   184,003,000
Total Commitment 325,000,000   325,000,000
BAML Facility      
Debt Instrument [Line Items]      
Outstanding balance 36,280,000   36,280,000
Total Commitment 36,280,000   125,000,000
CNB Facility      
Debt Instrument [Line Items]      
Total Commitment   $ 50,000,000.0  
CNB Facility | CNB Facility      
Debt Instrument [Line Items]      
Outstanding balance 30,500,000   0
Total Commitment 50,000,000 $ 50,000,000 50,000,000
MetLife Facility      
Debt Instrument [Line Items]      
Outstanding balance 131,807,000   135,145,000
Total Commitment 180,000,000   180,000,000
U.S. Bank Facility      
Debt Instrument [Line Items]      
Outstanding balance 43,045,000   148,475,000
Total Commitment 185,989,000   185,989,000
Notes Payable      
Debt Instrument [Line Items]      
Outstanding balance 56,155,000   0
Total Commitment $ 84,155,000   $ 0
v3.19.3.a.u2
DEBT - Narrative Disclosures (Details)
1 Months Ended 7 Months Ended 9 Months Ended 12 Months Ended 29 Months Ended
Dec. 13, 2018
Dec. 12, 2018
Dec. 21, 2017
Oct. 01, 2017
Dec. 31, 2017
USD ($)
Aug. 03, 2017
Sep. 30, 2019
Dec. 31, 2019
USD ($)
extension
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2019
USD ($)
extension
Nov. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
May 31, 2019
USD ($)
Funding agreements                            
Total Commitment               $ 1,471,424,000 $ 1,475,989,000   $ 1,471,424,000      
Outstanding balance               894,744,000 887,974,000   894,744,000      
Early extinguishment of debt costs               0 0 $ (768,000)        
Amount of debt discount on the initial draw down amount               $ 2,600,000            
Maximum                            
Funding agreements                            
Extension period of maturity date               12 months            
Notes Payable to Banks                            
Funding agreements                            
Interest rate margin (as a percent)               3.75%            
Outstanding balance                       $ 23,500,000   $ 32,400,000
Notes Payable to Banks | NORTH CAROLINA                            
Funding agreements                            
Outstanding balance                           $ 40,500,000
Notes Payable to Banks | NEW YORK                            
Funding agreements                            
Interest rate margin (as a percent)               3.00%            
Outstanding balance               $ 28,300,000     28,300,000      
Notes Payable to Banks | SOUTH CAROLINA                            
Funding agreements                            
Interest rate margin (as a percent)               2.50%            
Outstanding balance               $ 27,900,000     27,900,000 $ 34,600,000    
Secured term loan                            
Funding agreements                            
Total Commitment               $ 110,000,000 110,000,000   $ 110,000,000      
Number of extension periods available for maturity date | extension               1     1      
Extension period of maturity date               12 months            
Outstanding balance               $ 110,000,000 $ 110,000,000   $ 110,000,000      
Aggregate principal amount               $ 110,000,000     $ 110,000,000      
Secured term loan | LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)     7.20%         5.00% 6.00% 8.70%        
Repayments of debt         $ 45,000,000                  
Early extinguishment of debt costs                   $ 768,000        
LIBOR floor (as a percent)               1.00%     1.00%      
Percentage of accretion of original issue discount and associated costs               8.00% 7.60%   8.00%      
Secured term loan | Minimum                            
Funding agreements                            
Tangible net worth (as a percent)               80.00%            
Net proceeds (as a perccent)               80.00%            
Percentage of tangible net worth required to be maintained (as a percent)               65.00%            
Asset coverage ratio               110.00%            
Unencumbered asset ratio               120.00%            
Secured term loan | Maximum                            
Funding agreements                            
Debt Instrument Covenant Ratio of Debt to Tangible Net Worth               4            
Secured Term Loan, Extension Period One | LIBOR                            
Funding agreements                            
Debt instrument, interest rate,               0.125%            
Secured Term Loan, Extension Period Two | LIBOR                            
Funding agreements                            
Debt instrument, interest rate,               0.375%            
Secured Term Loan, Extension Period Three | LIBOR                            
Funding agreements                            
Debt instrument, interest rate,               0.75%            
U.S. Bank Facility                            
Funding agreements                            
Total Commitment               $ 185,989,000 $ 185,989,000   $ 185,989,000      
Outstanding balance               43,045,000 148,475,000   43,045,000      
U.S. Bank Facility | 30 day LIBOR                            
Funding agreements                            
Total Commitment               $ 186,000,000     $ 186,000,000      
U.S. Bank Facility | Secured revolving funding facility                            
Funding agreements                            
Line of credit facility               0.25%            
U.S. Bank Facility | Revolving master repurchase facility                            
Funding agreements                            
Number of extension periods available for maturity date | extension               2     2      
Extension period of maturity date               12 months            
U.S. Bank Facility | Revolving master repurchase facility | 30 day LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)               50.00%            
Non-utilization/commitment fee               $ 246,000 83,000          
U.S. Bank Facility | Revolving master repurchase facility | One-month LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)               2.25%            
U.S. Bank Facility | Secured funding facility                            
Funding agreements                            
Non-utilization/commitment fee                 0          
Wells Fargo Facility                            
Funding agreements                            
Total Commitment               $ 500,000,000 500,000,000   $ 500,000,000      
Outstanding balance               $ 360,354,000 274,071,000   $ 360,354,000      
Wells Fargo Facility | Secured revolving funding facility                            
Funding agreements                            
Number of extension periods available for maturity date | extension               3     3      
Extension period of maturity date               12 months            
Non-utilization threshold (less than)               75.00%     75.00%      
Non-utilization/commitment fee               $ 618,000 149,000 362,000        
Line of credit facility               0.25%            
Wells Fargo Facility | Secured revolving funding facility | Minimum                            
Funding agreements                            
Tangible net worth to be maintained               $ 135,500,000            
Tangible net worth (as a percent)               80.00%            
Net proceeds (as a perccent)               80.00%            
Wells Fargo Facility | Secured revolving funding facility | Minimum | 30 day LIBOR                            
Funding agreements                            
Interest rate margin (as a percent) 1.75%             1.50%            
Wells Fargo Facility | Secured revolving funding facility | Maximum                            
Funding agreements                            
Debt Instrument Covenant Ratio of Debt to Tangible Net Worth               4            
Ratio of recourse debt to tangible net worth               3            
Ratio of EBITDA to fixed charges               1.25            
Wells Fargo Facility | Secured revolving funding facility | Maximum | 30 day LIBOR                            
Funding agreements                            
Interest rate margin (as a percent) 2.35%             2.25%            
Citibank Facility                            
Funding agreements                            
Total Commitment               $ 325,000,000 325,000,000   $ 325,000,000      
Outstanding balance               126,603,000 184,003,000   126,603,000      
Citibank Facility | Secured revolving funding facility                            
Funding agreements                            
Total Commitment               $ 325,000,000     $ 325,000,000      
Number of extension periods available for maturity date | extension               2     2      
Extension period of maturity date               12 months            
Non-utilization/commitment fee               $ 388,000 143,000 165,000        
Liquidity to be maintained as a percentage               5.00%            
Line of credit facility               0.25%            
Citibank Facility | Secured revolving funding facility | Minimum                            
Funding agreements                            
Tangible net worth (as a percent)               80.00%            
Net proceeds (as a perccent)               80.00%            
Amount of liquidity to be maintained               $ 5,000,000            
Citibank Facility | Secured revolving funding facility | Minimum | 30 day LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)   2.25%           1.50%            
Citibank Facility | Secured revolving funding facility | Maximum                            
Funding agreements                            
Debt Instrument Covenant Ratio of Debt to Tangible Net Worth               4            
Ratio of recourse debt to tangible net worth               3            
Ratio of EBITDA to fixed charges               1.25            
Amount of liquidity to be maintained               $ 10,000,000            
Citibank Facility | Secured revolving funding facility | Maximum | 30 day LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)   2.50%           2.25%            
BAML Facility                            
Funding agreements                            
Total Commitment               $ 36,280,000 125,000,000   $ 36,280,000      
Outstanding balance               $ 36,280,000 36,280,000   36,280,000      
Period immediately preceding               12 months            
BAML Facility | Secured revolving funding facility                            
Funding agreements                            
Line of credit facility               0.125%            
BAML Facility | Secured funding facility                            
Funding agreements                            
Total Commitment               $ 125,000,000     $ 125,000,000      
Number of extension periods available for maturity date | extension               1     1      
Extension period of maturity date               12 months            
Non-utilization/commitment fee               $ 43,000 21,000 52,000        
Term of debt               2 years            
Facility used on average (as a percent)               50.00%            
BAML Facility | Secured funding facility | One-month LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)             2.00%              
BAML Facility | Secured funding facility | Minimum                            
Funding agreements                            
Tangible net worth (as a percent)               80.00%            
Net proceeds (as a perccent)               80.00%            
BAML Facility | Secured funding facility | Minimum | One-month LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)       2.25%                    
BAML Facility | Secured funding facility | Maximum                            
Funding agreements                            
Debt Instrument Covenant Ratio of Debt to Tangible Net Worth               4            
Ratio of recourse debt to tangible net worth               3            
Ratio of EBITDA to fixed charges               1.25            
BAML Facility | Secured funding facility | Maximum | One-month LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)       2.75%                    
CNB Facility                            
Funding agreements                            
Total Commitment                         $ 50,000,000.0  
CNB Facility | Amended City National Bank Facility                            
Funding agreements                            
Total Commitment                         75,000,000.0  
CNB Facility | CNB Facility                            
Funding agreements                            
Total Commitment               $ 50,000,000 50,000,000   $ 50,000,000   $ 50,000,000  
Number of extension periods available for maturity date | extension               2     2      
Extension period of maturity date               12 months            
Non-utilization/commitment fee               $ 136,000 166,000 $ 184,000        
Line of credit facility               0.375%            
Outstanding balance               $ 30,500,000 0   $ 30,500,000      
Period immediately preceding               12 months            
CNB Facility | CNB Facility | One, two, three or six month LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)               3.00%            
CNB Facility | CNB Facility | Federal funds rate                            
Funding agreements                            
Interest rate margin (as a percent)               0.50%            
CNB Facility | CNB Facility | One-month LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)               1.00%            
CNB Facility | CNB Facility | Base rate                            
Funding agreements                            
Interest rate margin (as a percent)               1.25%            
CNB Facility | CNB Facility | Minimum                            
Funding agreements                            
Tangible net worth (as a percent)               80.00%            
Net proceeds (as a perccent)               80.00%            
Facility used on average (as a percent)               75.00%            
CNB Facility | CNB Facility | Minimum | One, two, three or six month LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)               2.65%            
CNB Facility | CNB Facility | Maximum                            
Funding agreements                            
Debt Instrument Covenant Ratio of Debt to Tangible Net Worth               4.00            
Ratio of recourse debt to tangible net worth               3            
Ratio of EBITDA to fixed charges               1.25            
MetLife Facility                            
Funding agreements                            
Total Commitment               $ 180,000,000 180,000,000   180,000,000      
Outstanding balance               $ 131,807,000 135,145,000   $ 131,807,000      
MetLife Facility | Secured revolving funding facility                            
Funding agreements                            
Non-utilization threshold (less than)               65.00%     65.00%      
Non-utilization/commitment fee               $ 5,000 7,000          
MetLife Facility | Revolving master repurchase facility                            
Funding agreements                            
Total Commitment               $ 180,000,000     $ 180,000,000      
Number of extension periods available for maturity date | extension               2     2      
Extension period of maturity date               12 months            
Period immediately preceding               12 months            
MetLife Facility | Revolving master repurchase facility | 30 day LIBOR                            
Funding agreements                            
Interest rate margin (as a percent)           2.35%         2.30%      
Line of credit facility               0.25%            
MetLife Facility | Revolving master repurchase facility | Minimum                            
Funding agreements                            
Tangible net worth (as a percent)               80.00%            
MetLife Facility | Revolving master repurchase facility | Maximum                            
Funding agreements                            
Debt Instrument Covenant Ratio of Debt to Tangible Net Worth               4            
Ratio of recourse debt to tangible net worth               3            
Ratio of EBITDA to fixed charges               1.25            
Notes Payable to Banks                            
Funding agreements                            
Total Commitment               $ 84,155,000 0   $ 84,155,000      
Outstanding balance               56,155,000 $ 0   $ 56,155,000      
Short-term debt, increase in borrowing limit               $ 30,000,000            
v3.19.3.a.u2
DEBT - Maturity Schedule (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Principal maturities of secured funding agreements and unsecured debt  
2020 $ 711,986
2021 126,603
2022 0
2023 0
2024 56,155
Thereafter 0
Total 894,744
Secured term loan  
Principal maturities of secured funding agreements and unsecured debt  
2020 110,000
2021 0
2022 0
2023 0
2024 0
Thereafter 0
Total 110,000
Wells Fargo Facility  
Principal maturities of secured funding agreements and unsecured debt  
2020 360,354
2021 0
2022 0
2023 0
2024 0
Thereafter 0
Total 360,354
Citibank Facility  
Principal maturities of secured funding agreements and unsecured debt  
2020 0
2021 126,603
2022 0
2023 0
2024 0
Thereafter 0
Total 126,603
BAML Facility  
Principal maturities of secured funding agreements and unsecured debt  
2020 36,280
2021 0
2022 0
2023 0
2024 0
Thereafter 0
Total 36,280
CNB Facility  
Principal maturities of secured funding agreements and unsecured debt  
2020 30,500
2021 0
2022 0
2023 0
2024 0
Thereafter 0
Total 30,500
MetLife Facility  
Principal maturities of secured funding agreements and unsecured debt  
2020 131,807
2021 0
2022 0
2023 0
2024 0
Thereafter 0
Total 131,807
U.S. Bank Facility  
Principal maturities of secured funding agreements and unsecured debt  
2020 43,045
2021 0
2022 0
2023 0
2024 0
Thereafter 0
Total 43,045
Notes Payable to Banks  
Principal maturities of secured funding agreements and unsecured debt  
2020 0
2021 0
2022 0
2023 0
2024 56,155
Thereafter 0
Total $ 56,155
v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES - Commitments (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]    
Total commitments $ 1,909,084 $ 1,677,615
Less: funded commitments (1,692,894) (1,534,743)
Total unfunded commitments $ 216,190 $ 142,872
v3.19.3.a.u2
STOCKHOLDERS' EQUITY - At the Market Stock Offering (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Nov. 22, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Stockholders' Equity Note [Abstract]        
Sale of stock, price per share $ 0.01      
Aggregate offering price $ 100.0      
Subscription agreement shares issued   0 0 0
v3.19.3.a.u2
STOCKHOLDERS' EQUITY - Disclosures (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Jun. 30, 2018
Equity Incentive Plan        
Shares available for grant       1,390,000
Restricted stock activity        
Balance at the beginning of the period (in shares) 202,010      
Granted (in shares) 183,559      
Vested (in shares) (88,156)      
Forfeited (in shares) (12,020)      
Balance at the end of the period (in shares) 285,393 202,010    
Activity in the Company's vested and nonvested shares of restricted stock        
Compensation expense $ 1,880 $ 1,102 $ 581  
Total fair value of shares vested 1,312 854 347  
Weighted average grant date fair value 2,829 2,186 1,592  
Total compensation cost related to non-vested awards that have not yet been recognized $ 3,100 $ 2,300 $ 1,200  
Weighted-average period over which non-vested awards are expected to be recognized 2 years 3 months 18 days 2 years 1 month 6 days 1 year 11 months 12 days  
Directors        
Activity in the Company's vested and nonvested shares of restricted stock        
Compensation expense $ 343 $ 427 $ 317  
Total fair value of shares vested 373 405 347  
Weighted average grant date fair value 302 427 338  
Officer        
Activity in the Company's vested and nonvested shares of restricted stock        
Compensation expense 1,537 675 264  
Total fair value of shares vested 939 449 0  
Weighted average grant date fair value $ 2,527 $ 1,759 $ 1,254  
Restricted Stock        
Equity Incentive Plan        
Shares granted 737,087      
Future Anticipated Vesting Schedule        
2020 (in shares) 118,194      
2021 (in shares) 87,566      
2022 (in shares) 62,424      
2023 (in shares) 17,209      
2024 (in shares) 0      
Total (in shares) 285,393      
Restricted Stock | Maximum        
Equity Incentive Plan        
Award vesting period 4 years      
Restricted Stock | Minimum        
Equity Incentive Plan        
Award vesting period 1 year      
Restricted Stock | Directors        
Restricted stock activity        
Balance at the beginning of the period (in shares) 22,554      
Granted (in shares) 19,665      
Vested (in shares) (25,853)      
Forfeited (in shares) (4,034)      
Balance at the end of the period (in shares) 12,332 22,554    
Future Anticipated Vesting Schedule        
2020 (in shares) 11,498      
2021 (in shares) 834      
2022 (in shares) 0      
2023 (in shares) 0      
2024 (in shares) 0      
Total (in shares) 12,332      
Restricted Stock | Officer        
Restricted stock activity        
Balance at the beginning of the period (in shares) 179,456      
Granted (in shares) 102,300      
Vested (in shares) (62,303)      
Forfeited (in shares) (7,986)      
Balance at the end of the period (in shares) 211,467 179,456    
Future Anticipated Vesting Schedule        
2020 (in shares) 96,752      
2021 (in shares) 69,510      
2022 (in shares) 45,205      
2023 (in shares) 0      
2024 (in shares) 0      
Total (in shares) 211,467      
Restricted Stock | May 1, 2012        
Equity Incentive Plan        
Shares granted 35,135      
Restricted Stock | June 18, 2012        
Equity Incentive Plan        
Shares granted 7,027      
Restricted Stock | July 9, 2012        
Equity Incentive Plan        
Shares granted 25,000      
Restricted Stock | June 26, 2013        
Equity Incentive Plan        
Shares granted 22,526      
Restricted Stock | November 25, 2013        
Equity Incentive Plan        
Shares granted 30,381      
Restricted Stock | January 31, 2014        
Equity Incentive Plan        
Shares granted 48,273      
Restricted Stock | February 26, 2014        
Equity Incentive Plan        
Shares granted 12,030      
Restricted Stock | February 27, 2014        
Equity Incentive Plan        
Shares granted 22,354      
Restricted Stock | June 24, 2014        
Equity Incentive Plan        
Shares granted 17,658      
Restricted Stock | June 24, 2015        
Equity Incentive Plan        
Shares granted 25,555      
Restricted Stock | April 25, 2016        
Equity Incentive Plan        
Shares granted 10,000      
Restricted Stock | June 27, 2016        
Equity Incentive Plan        
Shares granted 24,680      
Restricted Stock | April 25, 2017        
Equity Incentive Plan        
Shares granted 81,710      
Restricted Stock | June 7, 2017        
Equity Incentive Plan        
Shares granted 18,224      
Restricted Stock | October 17, 2017        
Equity Incentive Plan        
Shares granted 7,278      
Restricted Stock | December 15, 2017        
Equity Incentive Plan        
Shares granted 8,948      
Restricted Stock | May 14, 2018        
Equity Incentive Plan        
Shares granted 31,766      
Restricted Stock | June 26, 2018        
Equity Incentive Plan        
Shares granted 67,918      
Restricted Stock | December 14, 2018        
Equity Incentive Plan        
Shares granted 57,065      
Restricted Stock | March 7, 2019        
Equity Incentive Plan        
Shares granted 102,300      
Restricted Stock | April 23, 2019        
Equity Incentive Plan        
Shares granted 19,665      
Restricted Stock | December 20, 2019        
Equity Incentive Plan        
Shares granted 61,594      
Restricted Stock Units | Officer        
Restricted stock activity        
Balance at the beginning of the period (in shares) 0      
Granted (in shares) 61,594      
Vested (in shares) 0      
Forfeited (in shares) 0      
Balance at the end of the period (in shares) 61,594 0    
Future Anticipated Vesting Schedule        
2020 (in shares) 9,944      
2021 (in shares) 17,222      
2022 (in shares) 17,219      
2023 (in shares) 17,209      
2024 (in shares) 0      
Total (in shares) 61,594      
v3.19.3.a.u2
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Earnings Per Share [Abstract]              
Net income attributable to common stockholders         $ 36,991 $ 38,596 $ 30,407
Divided by:              
Basic weighted average shares of common stock outstanding (in shares)         28,609,282 28,529,439 28,478,237
Weighted average non-vested restricted stock and RSUs (in shares)         237,359 127,221 72,708
Diluted weighted average shares of common stock outstanding (in shares)         28,846,641 28,656,660 28,550,945
Basic earnings per common share (in dollars per share) $ 0.34 $ 0.32 $ 0.34 $ 0.30 $ 1.29 $ 1.35 $ 1.07
Diluted earnings per common share (in dollars per share) $ 0.33 $ 0.31 $ 0.34 $ 0.30 $ 1.28 $ 1.35 $ 1.07
v3.19.3.a.u2
INCOME TAX (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Components of the company's income tax provision      
Total income tax expense (benefit) $ 515 $ 446 $ 178
ACRE Capital Sale      
Components of the company's income tax provision      
Current 114 84 25
Deferred 99 0 0
Excise tax 302 362 153
Total income tax expense (benefit) $ 515 $ 446 $ 178
Excise tax rate 4.00%    
v3.19.3.a.u2
FAIR VALUE (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Carrying value and estimated fair value of the financial assets on the consolidated balance sheet    
Loans held for investment $ 1,682,498 $ 1,524,873
Carrying Value | Level 2    
Financial Liabilities:    
Secured funding agreements 728,589 777,974
Notes payable 54,708 0
Secured term loan 109,149 108,345
Carrying Value | Level 3    
Carrying value and estimated fair value of the financial assets on the consolidated balance sheet    
Loans held for investment 1,682,498 1,524,873
Financial Liabilities:    
Collateralized loan obligation securitization debt (consolidated VIE) 443,177 270,737
Fair Value | Level 2    
Financial Liabilities:    
Secured funding agreements 728,589 777,974
Notes payable 56,155 0
Secured term loan 110,000 110,000
Fair Value | Level 3    
Carrying value and estimated fair value of the financial assets on the consolidated balance sheet    
Loans held for investment 1,692,894 1,534,743
Financial Liabilities:    
Collateralized loan obligation securitization debt (consolidated VIE) $ 445,600 $ 272,927
v3.19.3.a.u2
RELATED PARTY TRANSACTIONS - Narrative (Details)
1 Months Ended 12 Months Ended
May 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
quarter
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Related Party Transaction [Line Items]        
Management fee renewal term   1 year    
Incentive fees incurred   24 months    
Carrying Amount   $ 1,682,498,000 $ 1,524,873,000  
Outstanding principal   $ 1,692,894,000 1,534,743,000  
Affiliated Entity        
Related Party Transaction [Line Items]        
Base management fees as a percentage of stockholders' equity per annum   1.50%    
Incentive fee payable   $ 0    
Percentage multiplied to arrive at first value affecting calculation of incentive fees   20.00%    
Previous period for which core earnings are considered to arrive at first value affecting calculation of incentive fees   12 months    
Previous period for product of weighted average price per share and weighted average number of shares of common stock and other shares   12 months    
Percentage multiplied to arrive at difference of first value affecting calculation of incentive fees   8.00%    
Period whose fiscal quarters are considered to arrive at first value affecting calculation of incentive fees   12 months    
Minimum cumulative core earnings, number of quarters | quarter   12    
Minimum cumulative core earnings   $ 0    
Revenue from Related Parties   1,100,000 1,200,000 $ 381,000
Residential        
Related Party Transaction [Line Items]        
Carrying Amount   $ 40,900,000 $ 34,000,000  
Loan Purchase Commitments | NORTH CAROLINA | Senior Mortgage Loans | Industrial        
Related Party Transaction [Line Items]        
Loan purchased from affiliate $ 40,500,000      
Outstanding principal $ 34,900,000      
v3.19.3.a.u2
RELATED PATY TRANSACTIONS - Related Party Costs Incurred (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Related Party Transaction [Line Items]      
Payable $ 2,761 $ 3,163  
Continuing Operations | Affiliated Entity      
Related Party Transaction [Line Items]      
Incurred 10,581 11,212 $ 10,772
Payable 2,761 3,163  
Continuing Operations | Affiliated Entity | Management fees      
Related Party Transaction [Line Items]      
Incurred 6,311 6,268 6,188
Payable 1,581 1,576  
Continuing Operations | Affiliated Entity | Incentive Fees      
Related Party Transaction [Line Items]      
Incurred 1,052 1,150 381
Payable 378 540  
Continuing Operations | Affiliated Entity | General and administrative expenses      
Related Party Transaction [Line Items]      
Incurred 3,026 3,570 3,899
Payable 789 996  
Continuing Operations | Affiliated Entity | Direct costs      
Related Party Transaction [Line Items]      
Incurred 192 224 $ 304
Payable $ 13 $ 51  
v3.19.3.a.u2
DIVIDENDS AND DISTRIBUTIONS (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Nov. 08, 2019
Jul. 26, 2019
May 01, 2019
Feb. 21, 2019
Oct. 30, 2018
Jul. 26, 2018
May 01, 2018
Mar. 01, 2018
Nov. 01, 2017
Aug. 03, 2017
May 02, 2017
Mar. 07, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
DIVIDENDS AND DISTRIBUTIONS                              
Dividends per share amount paid (in dollars per share) $ 0.33 $ 0.33 $ 0.33 $ 0.33 $ 0.31 $ 0.29 $ 0.28 $ 0.28 $ 0.27 $ 0.27 $ 0.27 $ 0.27 $ 1.32 $ 1.16 $ 1.08
Total cash dividends $ 9,546 $ 9,526 $ 9,527 $ 9,520 $ 8,914 $ 8,323 $ 8,036 $ 8,008 $ 7,722 $ 7,717 $ 7,718 $ 7,690 $ 38,119 $ 33,281 $ 30,847
v3.19.3.a.u2
VARIABLE INTEREST ENTITIES (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Loan
Dec. 31, 2018
USD ($)
Loan
Jan. 11, 2019
USD ($)
Mar. 31, 2017
USD ($)
Variable Interest Entity [Line Items]        
Debt Commitment $ 894,744      
Carrying Amount $ 1,682,498 $ 1,524,873    
Floating Rate Notes, Weighted Average Coupon Rate, LIBOR Plus 1.85%        
Variable Interest Entity [Line Items]        
Number of properties collateralized for mortgage loan | Loan 16 11    
Collateral amount $ 515,900 $ 289,600    
Receivables related to repayments of outstanding principal $ 41,100 $ 51,600    
Offered Certificates        
Variable Interest Entity [Line Items]        
Prepayment fee, percent 1.00%      
Offered Notes        
Variable Interest Entity [Line Items]        
Prepayment fee, percent 1.00%      
Parent Company | Offered Certificates        
Variable Interest Entity [Line Items]        
Preferred equity fully funded amount $ 52,900      
Parent Company | Secured funding agreements        
Variable Interest Entity [Line Items]        
Carrying Amount 111,400      
Holdco | Offered Notes        
Variable Interest Entity [Line Items]        
Principal amount of certificates retained by wholly owned subsidiary of the entity 58,500      
Wells Fargo Bank National Association        
Variable Interest Entity [Line Items]        
Debt Commitment $ 360,354      
Notes Payable to Banks | Wells Fargo Bank National Association        
Variable Interest Entity [Line Items]        
Debt Commitment       $ 308,800
Notes Payable to Banks | Wells Fargo Bank National Association | 2019 FL3 CLO Securitization        
Variable Interest Entity [Line Items]        
Debt Commitment     $ 504,100  
Wells Fargo Bank National Association        
Variable Interest Entity [Line Items]        
Debt instrument, preferred equity component       $ 32,400
v3.19.3.a.u2
QUARTERLY FINANCIAL DATA (UNAUDITED) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]                      
Net interest margin $ 13,492 $ 13,145 $ 13,318 $ 12,246 $ 14,525 $ 13,984 $ 13,636 $ 13,137 $ 77,259 $ 55,282 $ 46,348
Net income attributable to common stockholders $ 9,660 $ 9,034 $ 9,755 $ 8,543 $ 10,018 $ 9,957 $ 9,303 $ 9,318 $ 36,991 $ 38,596 $ 30,407
Net income per common share-Basic (in dollars per share) $ 0.34 $ 0.32 $ 0.34 $ 0.30         $ 1.29 $ 1.35 $ 1.07
Diluted earnings per common share (in dollars per share) $ 0.33 $ 0.31 $ 0.34 $ 0.30         $ 1.28 $ 1.35 $ 1.07
Net income per common share-Basic and Diluted (in dollars per share)         $ 0.35 $ 0.35 $ 0.33 $ 0.33      
v3.19.3.a.u2
SUBSEQUENT EVENTS (Details)
12 Months Ended
Feb. 20, 2020
$ / shares
Feb. 10, 2020
USD ($)
Jan. 30, 2020
USD ($)
shares
Jan. 28, 2020
USD ($)
Jan. 22, 2020
USD ($)
$ / shares
shares
Jan. 21, 2020
USD ($)
Jan. 16, 2020
USD ($)
extension
Dec. 31, 2019
USD ($)
$ / shares
Dec. 31, 2018
USD ($)
$ / shares
Subsequent Events                  
Total Commitment               $ 1,471,424,000 $ 1,475,989,000
Common stock, par value (in dollars per share) | $ / shares               $ 0.01 $ 0.01
Outstanding principal               $ 1,692,894,000 $ 1,534,743,000
Carrying Amount               $ 1,682,498,000 $ 1,524,873,000
Subsequent event                  
Subsequent Events                  
Dividends declared per share of common stock (in dollars per share) | $ / shares $ 0.33                
Morgan Stanley Facility | Revolving master repurchase facility | Subsequent event                  
Subsequent Events                  
Number of extension periods available for maturity date | extension             2    
Extension period of maturity date             12 months    
Morgan Stanley Facility | One-month LIBOR | Revolving master repurchase facility | Subsequent event                  
Subsequent Events                  
Total Commitment             $ 150,000,000.0    
Interest rate margin (as a percent)             25.00%    
Diversified | Senior Mortgage Loans | Office | LIBOR Plus 3.65%, Due January 2023 | Subsequent event                  
Subsequent Events                  
Outstanding principal           $ 132,600,000      
Carrying Amount           $ 107,100,000      
Diversified | Senior Mortgage Loans | Office | LIBOR | LIBOR Plus 3.65%, Due January 2023 | Subsequent event                  
Subsequent Events                  
Basis spread on variable rate           3.65%      
Term of debt           3 years      
TEXAS | Senior Mortgage Loans | Multifamily | LIBOR Plus 3.25%, Due January 2023 | Subsequent event                  
Subsequent Events                  
Outstanding principal       $ 29,600,000          
Term of debt       3 years          
TEXAS | Senior Mortgage Loans | Multifamily | LIBOR | LIBOR Plus 3.25%, Due January 2023 | Subsequent event                  
Subsequent Events                  
Basis spread on variable rate       3.25%          
NEW YORK | Senior Mortgage Loans | Industrial | LIBOR Plus 5.00%, Due January 2021 | Subsequent event                  
Subsequent Events                  
Outstanding principal     $ 56,500,000            
Carrying Amount     $ 42,500,000            
Term of debt     1 year            
NEW YORK | Senior Mortgage Loans | Industrial | LIBOR | LIBOR Plus 5.00%, Due January 2021 | Subsequent event                  
Subsequent Events                  
Basis spread on variable rate     5.00%            
WASHINGTON | Senior Mortgage Loans | Multifamily | LIBOR Plus 3.00%, Due January 2023 | Subsequent event                  
Subsequent Events                  
Outstanding principal   $ 19,000,000              
Carrying Amount   $ 18,600,000              
Term of debt   3 years              
WASHINGTON | Senior Mortgage Loans | Multifamily | LIBOR | LIBOR Plus 3.00%, Due January 2023 | Subsequent event                  
Subsequent Events                  
Basis spread on variable rate   3.00%              
Common Stock | Subsequent event                  
Subsequent Events                  
Stock issued in the period (in shares) | shares     600,000   4,000,000        
Common stock, par value (in dollars per share) | $ / shares         $ 0.01        
Proceeds from Issuance of Common Stock     $ 9,500,000   $ 63,300,000        
Underwriter 30-day option | Common Stock | Subsequent event                  
Subsequent Events                  
Stock issued in the period (in shares) | shares         600,000        
Minimum | Morgan Stanley Facility | One-month LIBOR | Revolving master repurchase facility | Subsequent event                  
Subsequent Events                  
Interest rate margin (as a percent)             1.75%    
Maximum                  
Subsequent Events                  
Extension period of maturity date               12 months  
Maximum | Morgan Stanley Facility | One-month LIBOR | Revolving master repurchase facility | Subsequent event                  
Subsequent Events                  
Interest rate margin (as a percent)             2.25%